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SUMMARY: 
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The different steps of the process have been checked and some technical 
recommendations introduced. 
On the other hand, the consultant proposed to extend the present production to some 
anaerobic bacterial vaccines (blackleg, enterotoxemia) and in a second phase to the 
Newcastle vaccine, to fulfil! the urgent needs of the country. Estimates for laboratory 
equipments, refurbishments, calculation of production costs and training are 
proposed. 
The last chapter of the report introduces the problem of the financial management of 
this laboratory and its necessary self-sustainability in the future in the frame of a cost 
recovery system. 
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I - TERMS OF REFERENCE 
I - TERMS OF REFERENCE : REMINDER 
1. To ensure the vaccine centre is up to international standards or at least not 
sub-standard to the requirements in terms of: 
a) The infrastructure of the laboratories 
b) Minimal safety standards are maintained 
c) Ensure the quality of the vaccine is being maintained 
d) Testing regime for the vaccines is correct 
e) Quality of staff 
2. To come up with recommendations in terms of: 
a) Is it applicable for the ICRC to continue with its support for the 
vaccine production in accordance with the above requirements ? 
b) And if so what improvements should/could be made. 
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II - TIMING OF THE MISSION 
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II - TIMING OF THE MISSION 
Wednesday 24.03.1999 : 
);> A.M. : • International flight: Paris/Genova 
• Briefing in the ICRC Headquarters in Genova 
);> P.M.: Briefing (continuing) 
Thursday 25.03.1999: 
Departure in the morning for two international flights GENOVNLONDON -
LON DON/ISLAMABAD 
Friday 26.03.1999 : 
);> A.M.: 
);> P.M. : 
• Arrival in ISLAMABAD in the morning · 
• Domestic flight: ISLAMABAD/PESHAWAR 
• Welcome by a representative of the ICRC Sub-Delegation in 
PESHAWAR 
• Immediate transfer to KABUL by an ICRC aircraft 
• Welcome in KABUL by representatives of the ICRC Delegation in 
KABUL and transfer to the ICRC guest-house. 
Rest and consultation of documents. 
Saturday 27.03.1999: 
_>;. A.M. : Meeting with Mr. Daniel GAGNON Eco-Sec Delegate 
);> P.M. : • Consultation of documents 
• Preparation of the mission 
Sunday 28.03.1999 : 
);> A.M. : • Meeting in the ICRC in KABUL with Dr. A.H. NAWROZ, 
representative of ICRC for vaccine production and Mr. Daniel 
GAGNON (Eco-Sec Delegate) 
• General visit of the Veterinary vaccine production Laboratory in 
KABUL and meeting with Dr. A.H. NAWROZ and the technicians 
staff. 
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)i;> P.M.: • Continuing the meeting 
• Consultation of documents. 
Monday 29.03.1999: 
)i;> A.M.: • Meeting with Dr. A.H. NAWROZ 
• General technical evaluation of the Laboratory in KABUL 
)i;> P.M.: Continuing the work with technicians. 
Tuesday 30.03.1999 : 
)i;> A.M.: • Meeting with Mr. RODERICK CHARTERS (Eco-Sec Co-Ordinator) 
• Meeting with H.E. the Min ister of Agriculture of Afghanistan 
)i;> P.M.: • Visit of an ICRC Veterinary Clinic in KABUL 
• Meeting with Dr. A.H. NAWROZ 




• Briefing with Mr. RODERICK CHARTERS and his staff 
• Technical evaluation of the Anthrax vaccine production process in the 
Laboratory in KABUL. 
Continuing the evaluation and discussion of prospects. 
Thursday 1.04.1999: 
)i;> A.M. : • Continu ing the evaluation and discussion with the Laboratory's staff 
for the vaccine production strategies in the future. 
)i;> P.M. : • Week-end in Afghanistan 
• Consultation of documents 
• Writing the report 
Friday 2.04.1999 : 
)i;> A.M.: • Week-end in Afghanistan 
• Writing the report 
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);:> P.M.: Meeting in the laboratory in KABUL with the technicians to review the lay-
out of the present facilities and the needs of consumables for Anthrax, HS, 
Enterotoxemia and Blackleg vaccines. 
Saturday 3.04.1999 : 
);:> A.M. : • Meeting in the Faculty of Veterinary Medicine of KABUL with the 
Dean of the Faculty and his staff 
• Visit of a veterinary clinic in KABUL belonging to the Ministry of 
Agriculture and supported by FAQ 
• Meeting in the Ministry of Agriculture with representatives of the 
Veterinary Department 
• Visit of the sites of the Central Veterinary diagnostic and quality 
control laboratory and of the former veterinary vaccine production 
center both destroyed during the conflicts. 
);:> P.M. : • Review in the laboratory in KABUL of the costs of the vaccines and 
the needs of equipment. 
• Visit of an ICRC Veterinary Clinic in KABUL. 
Sunday 4.04.1999: 
);:> A.M. : • Meeting with Dr. LUTFUNAH (VTC) Master Trainer of FAO, 
veterinary monitor in KABUL. 
• Meeting in the veterinary vaccine production Laboratory to review the 
lay-out of the technical rooms. 
);:> P.M. : • Field visit 6 kms from KABUL with the responsible of the ICRC 
Veterinary Clinic for an Anthrax vaccination campaign of some sheep 
flocks 




• Meeting with Mr. RODERICK CHARTERS Eco-Sec Co-Ordinator 
• Meeting in the infectious diseases Hospital in KABUL. 
• Final meeting in the Veterinary vaccines production Laboratory in 
KABUL. 
• Meeting with Mr. RODERICK CHARTERS Eco-Sec Co-Ordinator 
• Final meeting in the ICRC Delegation with Mr. MARKUS DOLDER, 
head of the delegation and Mr. Roderick CHARTERS responsible of 
the agro-vet. Staff. 
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Tuesday 6.04. 1999 : 
~ A.M.: Domestic ICRC flights KABUUJALALABAD 
~ P.M.: Meeting in t e Madera Veterinary vaccines production Center and general 
visit of the laboratories. 
Wednesday 7.04.1999: 
Transfer by ICRC car: JALALABAD - PESHAWAR (Pakistan) 
Thursday 8.04.1999 : 
Final meeting in the MADERA office in PESHAWAR with representatives 
of FAO (ISLAMABAD), MADERA (PESHAWAR) ICRC (KABUL). 
Friday 9.04.1999: 
~ A.M. : Writing the report 
~ P.M.: Domestic flight PESHAWAR/ISLAMABAD 
Saturday 10.04.1999: 
• International flight ISLAMABAD/LON DON/PARIS 
• Arrival in PARIS at 8:45 p.m. local time. 
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Ill - PEOPLE ENCOUNTERED 
GENOVA - Switzerland 
+ Mrs Hendrika VAN BEEREN DONK RH/SAN 
+ Mrs Yannick MARQUIS RH/SANSECLO 
+ Mr. Pascal MAUCHLE OP/ASLAT/SO 
+ Mr. Thomas SEGHEZZI RH/SANSECLO 
+ Mr. Scott GARDINER OP/SANSEC/S 
KABUL - Afghanistan 
• ICRC: 
+ Mr. MARKUS DOLDER head of delegation 
+ Mr. David OVER LACK Health delegate 
+ Mr. Jean-Fran<;ois RAPIN Administrative Co-ordinator 
+ Mr. Daniel GAGNON Eco-Sec Delegate 
+ Mr. RODERICK CHARTERS Eco-Sec Co-Ordinator 
+ Dr. A.H. NAWROZ representative of ICRC and supervisor of the 
vaccine production laboratory in KABUL 
+ Dr. NOOR AHMAD Vet team ICRC 
+ Dr. RASHID! Vet team ICRC 
+ Dr. A. WASSEi ICRC Clinic in KABUL 
• MINISTRY OF AGRICULTURE OF AFGHANISTAN (KABUL) 
+ H.E.MAWLAWI ABDUL LATIF MANSOOR, Minister of Agriculture 
+ Dr. QARI JAMEEL President of the Veterinary Department 
+ Dr. ABDUL GHAFAR TORIALAY, Deputy President of the Veterinary 
Department 
+ Dr. AHSAN BARAKZAI, Chief of the preventives department and 
President of the KABUL Veterinary Surgeons Association (KVSA) 
+ MAWLAWI MOHAMAD YUSUF, Chief of the vaccine production 
• VETERINARY VACCINES PRODUCTION LABORATORY 
+ Mr. ALI MOHAMAD, VIRAL VACCINES, Responsible for the 
management of the laboratory, Government representative 
+ Mr. A. RUB, viral vaccines 
+ Mr. A. WAKIL, anthrax vaccine 
+ Mr. ABDUL SAMAD, enterotoxemia and blackleg vaccines 
+ Mr. A. AHAD, enterotoxemia and blackleg vaccines 
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• FACULTY OF VETERINARY MEDICINE (KABUL) 
+ Pr. AMlt--J UDDIN (Dean of the Faculty) 
• FAQ VETERINARY TRAINING CENTER (KABUL) 
• Dr. LUTFUNAH, Master trainer of FAO, Veterinary monitor in KABUL 
• INFECTIOUS DISIEASES HOSPITAL - KABUL 
+ MAWLAWI ABDUL MANAN, Head of the Hospital 
+ Dr. MOHAMAD QASIM, Men division responsible 
+ Dr. A. JALEEL HASSAN, Chief of Department 
JALALABAD - Afghanistan 
• MADERA VETERl~~ARY VACCINES PRODUCTION LABORATORY 
• Dr. GH. M. ARZO, responsible of the laboratory 
• Dr. M.S. TAHIR, Livestock sector co-ordinator 
• Dr. N. sAiFI 
PESHAWAR - PAKISTAN 
• MADERA- PESHAWAR 
• Dr. Jean-Fran<;ois CAUTAIN, Country Director 
• FAO - ISLAMABAD 
+ Dr. A. B. MEHRABAN, National manager 
+ Dr. A. A. MAJOK, Epidemiologist 
• GERMAN AFGHANISTAN FOUNDATION 
+ Dr. ABD UL GHA FOOR, Director 
10 
IV - ACKNOWLEDGMENTS 
11 
IV - ACKNOWLEDGMENTS 
The consultant is really deeply grateful to the whole staff of the ICRC delegation in 
KABUL and especially to MARKUS DOLDER and RODERICK CHARTERS for their 
warmful welcome during his stay in AFGHANISTAN. 
Many thanks to Dr. A.H. NAWROZ, representative of ICRC and supervisor of the 
vaccine production Laboratory in KABUL, and to all the staff of technicians of this 
laboratory for their friendly and active collaboration during his mission. 
Thanks too to the ICRC people of JALALABAD, PESHAWAR and ISLAMABAD for their 
excellent welcome service during the journey. 
12 
V - GENERAL CONTEXT OF LIVESTOCK 
IN AFGHANISTAN 
13 
V - GENERAL CONTEXT OF LIVESTOCK IN AFGHANISTAN 
85 % of the total population is involved in agriculture. 
According to different sources (MOA, FAO, MADERA) the number of animals 
should be in 1996-1997 as following: 






• Poultry : 
3 to 3.5 million (including 40,000 buffalos) 
15 to 20 million (including 4 million karakul) 
3 to 5.5 million 
300,000 
3 to 600,000 
130 to 150,000 
15 to 20 million 
Sheep, cattle and poultry are the main species for animal production in 
Afghanistan. 
Number of professionals involved in animal health in Afghanistan : 
• Veterinarians : 
• Vet-assistants: 
400 (educated in the veterinary faculty of KABUL) 
100 (educated abroad) 
900 







CHART OF THE VETERINARY 
DEPARTMENT OF THE MINISTRY OF 




Quality control of Preventives and treatment : 
the vaccines - quarantine 
(laboratory - control and inspection 
destroyed) - clinics 
- meat hygiene 







Partners involved in animal health and production : 
• ICRC vaccine production (KABUL) 
clinics 
husbandry 
+ MADERA: - vaccine production UALALABAD) 
clinics 
• D.C.A. : clinics 
• F.A.O. : 
training 
clinics, 
veterinary training centre, 
animal husbandry, 
diagnostics labs (4) 
meat inspection (limited) 
artificial insemination (limited) 
The ICRC delegation (Eco-Sec co-ordinator) in KABUL started 2 years ago a vet. 
Programme with, mainly, a support to the vaccine production laboratory in KABUL 
and to 2 veterinary clinics. 
This programme is situated in the general framework of strengthening the food 
chain, insuring animal production by the improvement of livestock health. 
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VI - PRESENTATION OF THE STAFF OF THE VETERINARY 
VACCINES PRODUCTION LABORATORY IN KABUL 
+ 5 veterinary assistants and laboratory technicians : 
• 
• 
Mean age of the staff: 50 years with 29 years of experience for each . 
Education : 
~ 3 years in the veterinary high school of KABUL 
>- 2 years and Yz in the institute of agriculture and technical training 
~ 1 year of specific training in KABUL sponsored by FAO, entitled 
"Laboratory technicians training Course" 
~ In addition the 5 technicians obtained grants for specialized training in 
foreign countries : 
- 2 technicians 6 months in RAZZI Institute Teheran (IRAN) and 3 
months in India (l.V.R.I. IZATNAGAR) for viral vaccines : Newcastle 
disease, Fowl-pox, Sheep-pox, rinderpest (tissue cultures) 
- 1 technician 6 months in the SOFIA Institute of Immunology 
(BULGARIA) for Anthrax and Haemorrhagic septicaemia vaccines 
production, 
- 1 technician one year in Czechoslovakia for blackleg, 
- 1 technician 6 months in India (IVRI - IZATNAGAR) for Anthrax, 
Blackleg, multicomponent clostridial vaccines. 
+ Dr. A.H. NAWROZ 
• Representative of ICRC and supervisor of the vaccine production laboratory in 
KABUL 
• B.V.sc. (5 years), M.V.sc. (3 years) India. Title of the thesis : "Detection of 
rinderpest Antibodies by micro-Elisa techniques". 
National diploma (eq) INDIA Training in microbiological diagnostic (9 months), 
• Genetic engineering and tissue culture training (INDIA) (3 months), 
• Trained for Anthrax, haemorrhagic septiceaemia vaccines and salmonella 
pullorum colored antigen production. 
+ Mean age of the staff of the laboratory : 
• Approximately 50 years around : it is necessary to plan specialized training for 
new technicians in the future. Young technicians and veterinarians are 
available in the country to renew the staff(?) 
• But no education since 1992 
• It seems it has started again in 1999 in the veterinary faculty of KABUL. 
• All these technicians have received a really good education and good trainings 
in the past. They have a long experience. The consultant confirms their standard 
technical competences for benches work. However, some refreshing courses 
should be necessary to update their present skills. 
18 
VII - REVIEW OF THE ANTHRAX VACCINE 
PRODUCTION PROCESS 
19 . 
VII - REVIEW OF THE ANTHRAX VACCINE PRODUCTION PROCESS 
Vll-1 - CHECK OF THE DIFERRENT STEPS OF THE PROCESS 
During his stay in KABUL, the consultant has checked in details the achievement of 
the following protocols : 
• Sheep blood collection, 
• Preparation of nutrient agar, blood agar, and Robertson medium 
• Bacterioscopy of the 34 F2 ,strain (gram staining, lack of motility and of 
haemolysis), 
• Purity controls for all steps, 
• Seed culture preparation inoculation and control, 
• Inoculation and collection of the mass culture in Roux flaskes with glass beeds, 
• Saponine saline preparation, 
• Dilution of the concentrate in a saponine solution, 
• Viable spores count, 
• Dispensing of the vaccine, 
• Safety controls on guinea pigs and sheep, 
• Laboratory skills of the staff. 
For the consultant, all the technicians apply, in general, the standard methods used in 
bacteriology for such a production. 
Vll-2. COMMENTS AND TECHNICAL RECOMMENDATIONS 
VI 1-2.1. Sterne strain 34 F2 of Bacillus anthracis : 
• History of this strain 
The worldwide strain currently used for prevention of Anthrax in animals was 
developed in 1937 by Sterne in South Africa. 
He discovered a rough avirulent variant of Bacillus anthracis when grown in serum 
agar with increased Co2. This variant was incapable of forming a capsule. It is a 
one-way mutation which cannot revert back to the encapsulated state. Sterne 
proposed this avirulent strain, termed "34F2 STERNE", for Anthrax vaccine 
production. More than 35 worldwide producers of this vaccine, including the 
veterinary vaccine production laboratory in KABUL, use this avirulent, 
immunogenic strain. 
• Specific bacteriological characteristics of this strain : 
• Bacilli, 
• Square ended, single or usually in long chains, 
• Gram+ 
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• Non motile, 
• Non encapsulated, 
• Form ing ellipso'fdal, central non bulging spores, 
• Vegetative cells are large (3-6 µm in length, and 1.0-1.2 µm in width), 
• "Rough" colon ies, 
• Lack of haemolysis 
• Avirulent for guinea pigs, sheep, goats and cattle in particular. 
• Master seed bank in the laboratory of KABUL: 
• Only 2 vials remaining provided in 1993 by the Razzi Institute (Teheran-IRAN), 
• Seed cultures: in deep agar, kept 2 or 3 months in the fridge, 
• Only 20 batches of 300,000 dosis each (6 million dosis) can be manufactured in 
the future from the 2 vials available currently. 
• Recommendations : 
• lmmediatly renew the stock of strains to secure the future productions. 
Different sources possible: 
• If possible, lalboratories in Turkey, India, Indonesia should provide new 
v ials through FAO, 
• If not, the best recommendation is to obtain the original strain from the 
"WHO/FAQ l111ternational laboratory for biological standards", CVL Wey 
bridge, New Haw, Addlestone, Surrey, KT 15 3 NB, United Kingdom. 
• A large seed lot must be prepared from the parent strain and preserved by 
lyophilisation. 
Vll2-2. MICROSCOPY 
• 1 microscope avai lable with : x 10, x 40 and x 100 (oil immersion), 
• 7 years old (N ingguang Trade mark), 
• No phase contrast outfit (necessary to check the motility) 
• Complete revision of this microscope is absolutely necessary by a specialized 
workshop, 
• Purchase of a new microscope is advised 
+ Gram staining: the stock of reagents must be renewed. 
Vll-2.3. MASS CULTURE MEDIUM 
• The KABUL's laboratory prepares currently the following medium : 
• Bacto nutrient agar dehydrated (bacto beefxtract, bacto peptone, bacto agar) 
23 g/1 OOO ml, 
• 0,5 % sodium chloride 
• final pH : 7.2. 
+ An improvement of the medium is proposed : in addition to the current medium 
use addition per 1 OOO ml of medium : 
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• An improvement of the medium is proposed : in addition to the current medium 
use addition per 1 OOO ml of medium : 
• Yeast extract (DIFCO) 2 g 
• Potassium di hydrogen phosphate 1 g 
• Di potassium hydrogen phosphate (as buffer) 5 g 
• PH 7.2. 
VI 1-2.4. Mass culture in Roux flasks : 
• Currently : - 4 days in incubator 
- 3 days in dark-room 
• Recommendations : 
• Control the evolution of the sporulation by bacterioscopy each day 
• This control should allow to reduce to 2 to 3 days instead of 4 days 
necessary to obtain 90 % of sporulation. 
• Remove the remaining liquid seed cultures in the Roux flasks after some 
hours of incubation to get a better and faster sporulation. 
• Advice : place the concentrate 1 h 65 ° in a water bath to eliminate the 
vegetative cells. 
Vll-2.5. Dilution of the concentrate to prepare the final batch of vaccine 
• Currently performed in saline with saponine 
• Recommendations : 
• To extend the conservation of the spores, glycerine should be used by dilution 
of the concentrate in a equal weight of glycerine 
• However glycerine is very expensive at this stage of production (should 
increase the cost 2 times) 
• The final concentration of saponine can be reduced to 1 %0 instead of 2.5 °A>o 
currently, if some important side effects are reported in the field (specially for 
goats). 
Vll-2.6. Batch control and tests on the final product 
V//-2.6.1. Purity test 
• The media currently used are: 
- blood agar 
- nutrient agar 
- nutrient broth 
- Robertson medium 
- sabouraud agar 
kept at 37 ° c 
kept at room temperature 
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The duration of incubation should be extended to 14 days according to 
international standard. 
V//-2.6.2. Viable spores count 
• During the stay of the consultant a spores count process was performed : 5 petri 
dishes were inoculated with 0.1 cc of the Anthrax vaccine concentrate at the 
dilution of 10 -7 
• The results were as follows : 
• Petri dish n° 1 ---. 34 colonies 
2 - 16 II 
3 - 17 II 
4 - 13 II 
5 - 11 
II 
TOTAL 91 colonies for 0.5 cc of concentrate 
• The final viable spores count is 91 x2 x 107 = 182.10 7 spores/ml of 
concentrate 
• Comments : it is considered as a good score. The average score is around 150-
107 spores/ml of concentrate. 
• The standard number of spores in the final product is 1.10 7 spores/ml (1 
cattle doses). It is advised to adjust the dilution of the concentrate over the 
number of spores required, which means 1.1to1.2 10 7 spores/ml. 
V//-2-6.3. Safety tests : 
• Guinea pigs 
• They are used only for the control of the concentrate 
• 1 ml of concentrate is diluted in 4 ml of normal saline (dilution 1/5) 
• 2 Guinea pigs are injected by the subcutaneous route respectively with 0.5 ml 
and 0.2 ml of the diluted concentrate and observed during 7 days. 
• Sheep 
• They are achieved on 3 non vaccinated sheep/batch inoculated respectively with 
0.5 ml, 1 ml, 5 ml of the final product (sampling : 1 % of the dispensed bottles) 
by the subcutaneous route. 
• Temperature is recorded twice a day, 3 days before vaccination, and during 15 
days after injection. 
• No comments : these tests are following the standard requirements. 
V//-2-6.4. Potency tests 
• No potency tests performed currently in this laboratory on guinea pigs 
• In routing production these tests are not considered as absolutely necessary for the 
well known 34 F2 strain vaccine. 
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• In routing production these tests are not considered as absolutely necessary for the 
well known 34 F2 strain vaccine. 
Vll-2.7. Proposal for an external official control of the Anthrax vaccine 
currently produced 
• The KABUL laboratory performs currently all the tests above mentionned and 
introduced the consultant the control forms for each batch manufactured (see 
Appendix 1). 
• During the second semester of 1998, Anthrax vaccine samples were sent to the 
veterinary research Institute of PESHAWAR (Pakistan) for an external control : the 
vaccine batch submitted to this control passed the tests of purity, safety, spore count 
performed, see results in Appendix 2. 
• However, it is advised by the consultant to handover vaccine samples of a current 
vaccine batch for an official control to the FAO/PANVAC Laboratory in DEBRE-
ZEIT (Ethiopia) to perform, once, a complete testing of the Anthrax vaccine 
manufactured in KABUL (viable spores count, purity, safety, potency tests). 
+ With the agreement of the ICRC delegate in KABUL, the consultant has carried two 
bottles of a new Anthrax vaccine batch back to France, and will handover 
immediately to the FAO/PANVAC-Laboratory. 
+ References of this laboratory: 
PAN AFRICAN VETERINARY VACCINE CENTER (PANVAQ 
C/o FAO - P.O. BOX 5536 
ADDIS-ABABA (Ethiopia) 
Tel: 00 251-1 33 88 44 
Fax: 00 251-1 33 80 01 
e.mail : panvac@telecom.net 
+ The cost of a complete control is : 700 US $ (see an estimate from PANVAC in 
Appendix 3). 
Vll-2.8. Storage of the final vaccine 
+ Maximum 6 months 
+ The vaccines are currently stored in an air-conditioned room located in the ICRC 
Delegation in KABUL. 
+ According to the standards, it seems necessary to implement a cold room ( + 4°C) 
directly in the laboratory. 
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Vll-2.9. Reminder : duration of immunity 
• A single inoculation provides effective immunity for about nine months. 
• Effective immunity develops within a week of vaccination 
• An annual booster dose is adequate to ensure permanent immuno-protection. 
Vll-2.10. Reporting on the Anthrax vaccine produced by the KABULS's 
laboratory 
+ Two batches manufactured equivalent to 850,000 sheep doses : they passed the 
purity and safety tests (sheep) 
• They have been dispatched as follows : 
• 5,000 doses : 
• 200,000 doses : 
• 200,000 doses : 
• 20,000 doses : 
• 344,000 doses: 
• 40,000 doses : 
Ministry of Agriculture (Vet.Clinics) 





TOTAL: 809 OOO doses dispatched 
• 1 51 batch : Free of cost 
• 2°d batch : 344,000 sheep doses bought by FAO (0,25 PKR/doses) corresponding 
to 1,650 US$ around = 4,800 US$ 1 million doses 
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VIII - GLOBAL NEEDS OF VETERINARY VACCINES FOR 
AFGHANISTAN 
+ Brief history of the veterinary vaccines production in Afghanistan : 
• Since 1944, Rinderpest vaccines (lapinized, caprinized, freeze-dried) have been 
produced in Afghanistan with the support of FAQ. 
• Between 1971-1977, the French government funded the establishment in 
KABUL (GARGHA) of a PASTEUR INSTITUTE which produced human and 
veterinary vaccines (sheep-pox, fowl pasteurellosis, enterotoxemia, 
haemorrhagic septicaemia, anthrax, newcastle). 
• All productions stopped in 1992 and restarted in 1997-1998 (Madera and the 
laboratory of KABUL). 
+ Estimated needs of vaccines : 
Considering different sources of information (FAO, MOA, MADERA ... ) and taking in 
account the present competences of the two existing laboratories (KABUL, MADERA), 
three levels of priorities are identified : 
Priorities Vaccines Needs/year 
1 ANTHRAX 15 to 20 million doses (all ruminants) 
ENTEROTOXEMIA 4 million doses 
BLACKLEG 1 million doses 
2 HAEMORRHAGIC SEPTICAEMIA 500,000 doses 
CCCP 150,000 doses (?) 
NEWCASTLE DISEASE 5 million doses 
SHEEP POX 1 million doses 
3 PPR 1 to 3.5 million doses 
FOWL POX ? 
GUMBORO ? 
+ Comments: 
• The production of anthrax vaccine is the "number one" priority considering that 
it is a zoonotic disease ! 23 human cases reported in 1997 and 20 in 1998 by 
the infectious diseases hospital in KABUL, 
• Anaerobic vaccines (Blackleg - Enterotoxemia) are important for all ruminants 
(cattle, sheep and goats). 
• Newcastle disease vaccine : 
• 8 millions of doses are imported illegally (from Pakistan) , each year ; this 
situation is not satisfactory, because the cold chain is not respected the 
vaccines are very often contamined. 
• In January 1999, for instance, 24,000 young layers died of this disease in 20 
poultry farms around KABUL. 
• In the district of KABUL, 900 breeders are implemented. They need 2 million 
doses of this vaccine per year. 
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IX-GENERAL STRATEGY PROPOSED FOR THE LABORATORY 
OF KABUL 
• Because of political uncertainties in Afghanistan and for technical security reasons, it 
is proposed to set up the bacterial vaccine processes in the 2 laboratories (KABUL, 
JALALABAD). 
+ For KABUL the consultant proposes 3 steps: 
);;- To strengthen immediately the anthrax vaccine production, 
);;- To implement, as soon as possible, the production of the enterotoxemia and 
blackleg vaccines. 
);;- To get ready to set up the Newcastle disease vaccine process followed by the 
PPR vaccine which require new refurbished facilities specific for the viral 
vaccines production. 
29 
X - FUTURE PROSPECTS FOR THE 
PRODUCTION OF BACTERIAL VACCINES IN 
THE LABORATORY OF KABUL 
30 
X - FUTURE PROSPECTS FOR THE PRODUCTION OF BACTERIAL 
VACCINES IN THE LABORATORY OF KABUL 
X-1. ESTIMATE FOR LABORATORY EQUIPMENTS: 
To fulfil! the first 2 steps (bacterial vaccines) it is necessary to provide the following 
equipments : 
• One horizontal cylindrical autoclave with a capacity of 8 flasks of ten liters 
on 2 shelves (2 x 4) 
• One bench freeze dryer 
• One laminar air flow cabinet (with a manometer for differential pressure) 
• One microscope (with different objectives and a phase contrast device) 
• One de ionizer 
• One conductimeter 
• One centrifuge (top speed 4,000 RPM for 10 ml tubes maximum) ... .. 
• One hot air oven 
• One anaerobic jar with gas packs 
• One stop watch timer 
• One shaker-mixer (auto vortex) 
• One stabilizer (for the laminal air flow cabinet or the microscope) 
• One digital balance (0.1 to 100 g minimum) 
• One Ph meter (with buffer solutions ph 7 and 4 
• One stainless steel bucket 
• One water bath 
• One capping and decapping machine (including jaw devices) 
• Two magnetic stirrers (for two items) 
- for dispensing (10 liters volume) 
- for laboratory use (1 liter volume) 
• Stirring bars (different sizes) 
• On vacuum pump 
• One mincing machine 
• One seitz filter (2 liters capacity) 
• Five bunsen burners (for 5 pieces) 
• One computer + printer 
• One stand-by generator 5-10 KVA 
• Different glass wares and miscellaneous including pipettes, conical pyrex, 
petri dishes, balloons, disposable syringes and needles, funnels hot air oven 
indicators, canisters, glass beads, rubber stoppers, aluminum caps 
• SUB-TOTAL: 
• + 30 % for transportation from EUROPE to AFGHANISTAN 






























N.B. - It is advised to buy directly in Europe through ICRC (Geneva) w ith direct 
transport Europe-Afghanistan (not through Pakistan because of customs taxes), 
- purchasing in Pakistan through local companies should cost 2 to 2.5 more!! 
+ See technical specifications for laboratory equipments from BDH-MERCK catalogue 
in Appendix 4 . 
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X-2. ESTIMATE FOR THE REFURBISHEMENT OF THE PRESENT FACILITIES 
• For the production of bacterial vaccines (anthrax, enterotoxemia, blackleg) it should 
be necessary to refurbish some new rooms within the existing surface of 
laboratories devoted at the moment exclusively to the production of the anthrax 
vaccine. 
• The new complete list of rooms is the following: 
Main entrance 
t 





corridor Packing room 
Dispensing room 
* Cold room for Walk-in 
anthrax final vaccine incubator 
30 m3 30 m3* 
Media preparation room * Culture room 
(enterotoxemia 
Culture room blackleg) 
(anthrax + HS) 
*New rooms 
• Another preparation room for anaerobic media called "boiling room" will be 
located outside, within the compound in a container. 
• General estimate for the rehabilitation work: 
• Additional refurbishment of the new rooms: 
• Windows glasses: 
• Linoleum : 165 m2 : 
• Waste drainage : 
• Glass wool for insulation (cold room and walk-in incubator) 
• Thermoregu lation equipment (walk-in incubator) 








TOT AL ................................................................................................ 16,500 US $ 
• See in Appendix 5, for information, a cost estimation drawn up by A. 
MEISSMER/ICRC-constructor KABUL on the 21/07/1998. 
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X-3. CALCULATION OF THE PRODUCTION COSTS: 
+ Reminder : inventory of the existing chemicals and equipements in the laboratory of 
KABUL introduced by Dr. NAWROZ. See in Appendix 6. 
+ Estimated production costs : 
Taking in account informations from the technicians staff 
• Anthrax vaccine: 1 millions doses : 
(sheep doses : 0,5 ml) 
• Enterotoxemia vaccine : 
• 1 million doses monovalent vaccine: 
( sheep doses : 1 ml) 
• 1 million doses bivalent vaccine : 
(sheep doses : 2 ml) 
• blackleg vaccine : 
• 1 million doses monovalent vaccine: 
(sheep doses : 1 ml) 
• 1 million doses bivalent vaccine: 






+ See protocols of production of the different bacterial vaccines in KABUL in 
Appendix 7 (drawn up by Dr. NAWROZ). 
X-4. FEASIBLE ANNUAL BACTERIAL VACCINE PRODUCTION IN KABUL 
For the first year (should be increased later) 
+ Anthrax : 5 million doses 
+ Enterotoxemia : 1.5 million doses (bivalent) 
• Blackleg : 1 million doses (bivalent) 
+ Haemorrhagic septicaemia : 500,000 doses 
X-5. TRAINING 
• To renew the staff it seems more adequate to take on veterinary doctors rather than 
technicians. 
+ Upgrading in microbiology is necessary: general courses (1 year) 
• Specialized training for vaccine production recommended abroad (bacterial and 
viral vaccines) . 
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XI - PRELIMINARY PROPOSAL FOR A NEWCASTLE VACCINE 
PRODUCTION UNIT IN THE LABORATORY OF KABUL 
+ New laboratories are necessary: 
- dispensing room 
- incubation room 
- inoculation room 
- Freeze drying room 
- Deep freezer room 
- Office 
+ Additional equipments : 
• Eggs incubation (300 eggs) 
• Freeze dryer 
500 vials (5 m I) 
• Deep freezer 
• Laminar air flow cabinet: 
• Tester for vacuum in ampules: 
• 8,000 rubber stoppers 
• 8,000 aluminum caps 
• 1,500 embryonated eggs 
TOTAL: 
+ Production : 
• In ampules 
Vials 
48,500 to 53,500 US $ (1 st year) 
3 million doses/year 151 year 
100 doses 
400 doses (5 m I) 
• 200,000 doses I batch 
• 16 batches I year : 3 million doses 
to 
1,500 us$ 






• See protocols of production of different viral vaccines in Appendix 8 (drawn up by 
Dr. NAWROZ). 
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XII - VISIT TO THE MADERA VETERINARY VACCINES PRODUCTION 
LABORATORY JALALABAD (Afghanistan) 
EU project: Production launched in october 1997 
+ The consultant did a short visit: no commitment for an evaluation of this laboratory 
+ LABORATORY : 
• "Basic" facilities and equipment, unsuitable environment (no protection for 
contaminations). 
• Animal husbandry close to the dispensing and incubation room 
• Good store : a lot of consumables (chemicals, peptones, glass wares) necessary for 
the production. 
+ Anthrax vaccine production : 
• Seems to be in agreement with the international standards 
• F 34 Sterne strain freeze-dried (from LAHORE - PAKISTAN and from IRAN) 
• Same process as in KABUL for: 
- production (Roux flasks) 
- control (purity, safety, spores account) 
- Average for concentrate 150 10 7/ml = correct 
• Vaccine: free of charge 
+ Blackleg vaccine : Ch. Chauvoei only 
• Strain : Lahore/freeze dried + Afghan 
• Process: classic: potency test: guinea pig 
• Vaccination challenge 
• No septicum vaccine production. 
• Enterotoxemia vaccine: classic process 
- Cl. Perfringens type B and D 
- Alum hydroxide precipitation (10 %0) 
• CCPP vaccine: F 38 strain 
One batch only 
• No viral vaccine production planned in the near future 
• Present annual capacity of the MADERA laboratory 
• Anthrax: 5 million doses/year 
• Enterotoxemia: 400,000 " " 
• Blackleg : 500 ,00 " " 
• H.S.V. : 200,000 " " 
• CCPP: 150,000 " " 
• Staff : - 2 veterinarians 
- 4 laboratory technicians: same level as in KABUL 
- 3 assistant technicians 
• Anthrax vaccine : Control in the PESHAWAR research veterinary institute : same as 
KABUL 
• See in Appendix 9 a brief report introduced by Dr. ARZO on the bacterial vaccines 
production in this laboratory. 
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XIII - REPORT OF THE FINAL MEETING IN PESHAWAR (PAKISTAN) 
This meeting was held in the MADERA Office in PESHAWAR on the 8th of April 1999 
with representatives of FAO (ISLAMABAD), MADERA (PESHAWAR), ICRC (KABUL). 
The participants agree to consider that 2 veterinary laboratories manufacturing the 
same bacterial vaccines are necessary in Afghanistan to partially secure the needs, 
taking in account the present situation of the country. 
A shared production planning should be as follows for the first year: 
Vaccines Estimated needs M.O.A. KABUL MADERA JALALABAD of Afghanistan Laboratory Laboratory 
Anthrax 
1 S-20 million doses 
SM SM 
all ruminants 
Blackleg 1M 1M S00,000 
Enterotoxemia 4M 1,S M 400,000 
Haemorrhagic-
500,000 S00,000 200,000 
septicaemia 
CCPP lS0,000 1 S0,000 
Newcastle SM 3M 
Sheep-pox 1M 
The F AO representatives declare that : 
+ FAO is a potential client: 
See a letter from FAO dated 8/11/1998 to ICRC and MADERA confirming annual 
requirements for vaccines in Appendix 10. 
+ Cattle are important for the economy of Afghanistan 
• PPR vaccine is a priority : 
• This disease has been identified in 42 districts in the country. See data of a 
sero-monitoring survey in Afghanistan by FAO in Appendix 11. 
• 1 to 3,5 million of doses of the homologous vaccine are requested. 
• Currently, PPR vaccines are imported in Afghanistan from Jordan by FAO. 
• FAO strongly support a possible local production of this vaccine in the 
MOA Laboratory in KABUL. 
+ The consultant informs the participants that Dr. Adama DIALLO (CIRAD-EMVT 
Montpellier), FAO and OIE PPR-expert, can give, on request, technical assistance 
for a transfer of technology in Afghanistan of the PPR homologous vaccine 
production process. 
+ Final remark on the shelf life of Anthrax vaccines : 
• It is limited to 6 months, 
• The manufacturing laboratories need to have a schedule of field dispatching 
from FAO to establish a coordinated production planning between the 2 
laboratories. 
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XIV - CONCLUSION 
XIV - 1. The consultant considers that for the Anthrax vaccine production process 
performed in the MOA Veterinary Laboratory of KABUL, the competence of 
technicians are good and the production protocols are, in general, standard, 
referring to the OIE requirements for this vaccine described in the OIE Manual 
of Standards for Diagnostics Tests and Vaccines 1996. 
XIV - 2. However, the technical recommendations in this report for the Anthrax 
vaccine production have to be reconsidered, and the final appraisement of 
this vaccine will be transmitted by the consultant to ICRC regarding the 
official testing of two samples (50 ml) of the Anthrax vaccine produced in 
KABUL in process in the PANVAC/FAO Laboratory of Debre-Zeit (Ethiopia). 
The two samples have been handed-over by CIRAD-EMVT at the end of the 
present mission for the following ~esting : 
- purity, 
- spores count, 
- safety (guinea-pigs, small ruminants) 
- efficacy (guinea-pigs) 
XIV - 3. To comment on the "touchy" problem attached to the term "Anthrax" the 
correspondence addressed by the Chief of the veterinary department to 
ICRC of the MOA in KABUL (see in Appendix 12) has to be considered. On 
the other hand, anyone, in any country can divert the vaccine production 
for "a malicious use" isolating a virulent strain directly for the soil or from 
necropsied animals. 
XIV - 4 On the other hand, to fulfil I the standard operating procedures (SOP) and to 
extend the production to some other bacterial vaccines, the improvement of 
the environment of the MOA Laboratory is absolutely necessary : 
• Complementary refurbishment of the laboratory room has to be 
achieved, 
• New equipment must be provided 
• The permanent and sufficient stock of consumables has to be 
secured. 
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XIV - 5. As described in C apter XIII it is advised to strengthen in parallel production of 
the bacterial and viral veterinary vaccines needed for livestock, on two sites: 
• M.O.A. Laboratory (KABUL) 
• MADERA Laboratory UALALABAD) 
XIV - 6. To conclude, the consultant would like to highlight one major problem, the 
different partners involved in veterinary vaccines production in Afghanistan 
will face, inevitably in the near future : that is clearly the financial 
management of the MOA Laboratory in KABUL to improve its capacity 
building. This structure has to move, step by step, from the present status of 
complete support by ICRC to self sustainability in the frame of a cost recovery 
system. 
The implementation of a steering committee previously proposed with the 
participation of ICRC, FAO, MADERA, Afghanistan Veterinary Association, 
MOA, will be very helpful in this context. 
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During the stay in KABUL, the consultant has transmitted some scientific articles to 
Dr. NAWROZ, mainly on Anthrax and PPR. 






pate. JI .. ': i.r - 9 'l 
Lot. No .. .1. .... 
Strain 3 ·~··· f~ 
Name of vaccine ./1.Yrfti/(l.~ .. .Spo..fe. Vcuc;fJ._e 
Date of seed culture .. J. .i.J . '·· i.J .. ~ .. .J.~. q g 
Date of mass culture .. l.~ .... • .. . iJ. .... ' .... 1 .1~9 ~ 
Date of formalisation (bacterins) ............ . 
Date of Harvest -~./L ~ .• .. i.> ... \ . ..l~.Ji 
Date of I st guinea pig test .. , f."{ . ~.3 . ~. q .'8 
Date of 2nd guinea pig test ........•........... 
Date of spore count .J. .3 .. ~ .. 3 .... ~ .. .I.~ j ~ 
No spore /ml .. ~. 1:-.9. .. 0o .. o.o.o. .a .o 
possible doses of vaccine · "i · -1>~ .. o. o.c,-, 
Date of final spore count ,i;o. ., . :~ ..•. . \ .~ 13 
Date of sterility test .1,q,.,. 3 .. ·'·. i.'1 . i . 8 
If repeated ..... ... ..... ... ........ .......... ......... . 
Date of safety test 'h.1 .. 1 .. . ~ .. ..... \ .1. .~ .. l--
Lot produced by .. H .. ' .. W.ct.\<J:. L. ... ... 
~ L 
Lot tested by .... ;1-.. ~ .. ~Y . a..K.L ... ~ ..... 
Date of dispatch .1.D .. . A.\?.f;.L. ..... \q.1.? 
Result '?.~0.5. fa c-! °}Y · 
Result .$.d.1.S. f~Y...cto 7 
Assisted by 
fb .. 5.a.,~ _<-t{l 
. n L 4 .. ~- . .rt..ha.c..... ~ 
'.4-1 ;.. ,. t4 0 kt{,· ... , ....... 




TEST I BEACH NO: 
Animal spece :_G=o"'-'aJ""""'------- Breed : A/ af; Ve Age : .2_, II C 7 
Le n.. f 11 ._ • · J.J_ s ho r ± uo ( Y1 Sex : fa.ma, Marking : J12.llf)_tJ.Ul-1~''----~""""~l_l ...LJl.L__,,l _ _l__.IJ_:.L.l_---L~J..J.L'-""-'--L-!-----
Date of inoculation : {?"' 6 ' 9 g Time : ~lfl__-l:P~filill ____________ _ 
5fi: With Strain : 3 y f i. fty.1fll a -J.. Method of Inoculation : -------J_u...,_,___ ____ _ 
Amount of ilnoculum : 0 ( 6 ml 
Month 
~ . v 




a p a ' p a i p a pap a · p a p a · p a p a , p a , p a : p a pa pap Finding in followings 
Hour 
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C -Day----+-~12--i-13----r14---r1-=---is lr,:---Gr,-17 i:--18 lal9 ""1:""110 T,,,, Tj12 h:l1 3h.114~,,:-is 1----L.-~lnte=stine-
(STILL ALIVE ). (DIED). (FILLED J ON : ________________ ___ _ 
~\~\_c:...s Vw~,~ ~Cl~~"' f~ 
~ '<!:..._ ""-~ "tf .,___ s t... t ~ ~c...t "'-..._ 
TEMPERATURE CHART 
TEST I BEACH NO: 
Animal spece :._Cr-o __ J _____ _ Age : L VC 
> 
Sex : fa.. maL e Malting: w h; .f e foch~ ~ wi-tt; 
n~:_4----P~m~~~~~~~~-Date of inoculation : 'i? ' b ' i i 
Wrth Strain : 3> Lj f L .9..1.f ca ?<. Method o11nocu1ation: ___ _,S &.__~=-------- ® 
Amount of ilnoculum : __ f_)11~_l ____ _ 
Mon~ ~ '-b'- ''l q 8 :ru.ne . Remar1ts • v 
Date s 9 I o t I IL 13 I 'I 15" tl 11 18 11 J..,D tl t.2., Autopsy 
a p a 
Hour 
p a p a ; p a l p a p a p a p a p a p a p a p a ; p a p a p Finding in follow'ings 
I I organs : 
.8 ' Local lesion . ' --------. 
.6 1 ~ I I - -- ·--- - --- - · - --- ---· .4 - ---- - --- - - ----------·-
.2 ----·-- -------
c l 
.8 : ' I Liver - --- ------ --- - --------
: .6 I I -- · - - ------------
! .4 I -- --· - -- - -- --- -----
.2 I I ! -- - -·----- - · - ---·--





.6 (\ --- ------
'\ i 
----
.4 I --- -·- ---- --- ----· .2 \ I -- - - ---- - - -- - -
\ i I 
.8 \ I I Lungs -- - - - ---- ---
'\. I .6 ! ! 
\ c,...---- \ -- V_-.4 ...., ) \ /V1 \ -----\-- - -.2 / ' 
f)'~ I v, I 
.8 v I Spleen - v---- - --- -.6 - - ---- - - ·-· .4 ----- -- - - - - · - - -- - - - --.2 -- -- - - - --- --- -
.8 Kidneys - - - - - ----.6 - - - - - - . -- -·--
. 4 
- - - --· - - -- -----·-.2 -- -- - - -· -- .. - -- - - - - ----- -
c 
.8 Stomach - - - --- -- - - - ·- - ---.6 I - - - -- - -----
.4 . - - - - ·- ---- -- -I .2 
- - - - - -I 
Day 1 12 13 14 15 16 17 18 19 110 111 112 113 11• 115 I Intestine 
{ STILL ALIVE ). {DIED) . {FILLED ) ON : ____________________ _ 
JEME_ERAJURE_ C_HARJ 
TEST I BEACH NO: f2 eh ' 6;_ Ut f 
Animal spece :_G~--'-o~a=-i _____ _ Breed : A/g'.. t ;V t: Age : ~3........,,._v~,C ____ _ 
7 
Sex: fa ?(l a..f e Marking: Black Lt..> i th w h ,· +e 
Date of inoculation : '6 " 6. " l J? Time : __,ij~· .... £~\TI~---------------
With Strain: 1, 4 f i• 4vitlfr1p.: Method of Inoculation : ____ ;,,_~~{'...=---------
Amount of ilnoculum : ---'-S..__--'-m-'--l'-------
Mont~ •V 8•6 .JlLne Remarks 
Date 'l, q jo (I l'.h \~ Jlf l') /6 - 11 \';? I~ !l,V 1'} .2,.2 Autopsy 
Hour 
a P a p Finding in followings 
43 c organs 
.8 
.6 
Local lesion I i I I : ' ' -t-i _, ___ ; ______  
--·- --~--'- --·- --- --'- -
LJ_ _______ ;_ · 
.4 ! ! I I ! I • 
.2 
- """T----- ----i---t- -- - ·------ ~ - -
___ .___ , - ' _ _J _ _ 
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APPENDIX 2 
RESULTS OF A CONTROL . OF AN ANTHRAX 
VACCINE BATCH EXECUTED IN PAKISTAN 
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STAN!lAl\DIZATICN/QUALITY'CCNTF.OL OF A.s.v. 
PREP ARBD BY ICI\C K AHUL 
~~~~~~~~~~~~ 
Please refer.to the subject cited above. 
The · A' Vltbr~ Spore V:-iccin e bot:l ~ of 50 ml glass 
. Packing received from you on 25 .. 9.93 was processed as unders-
1. . Contamination Control 
Blood ag&r, MacCoal:- .ly' _s agar, TryPtose agar nnd 
Saborau1d dextrose a1rnr were cul".;ureri with vari.oua dilutions of 
.:> 
the sample. Saboraud dextrose e~ar plates were incubated at~;D C 
for 96 houre while the rest · of the .111edi a plat ea and tubes were 
0 
incubated at 37 C for 48 hours. No co ·1~aminotion vas detected. 
2. · Labo1·atory animal inoculRti on 
,, 
Tvo albi:i. omice and two . !i - ~' :net;l pigs were inocul1'.ted · ~;ctt. 
o. 25 ml E:.nd 0.5 ml in trap eri. ton eally rasp ecti vely. These animals 
were kept under observation for ten !'lays. No untoward reactions 
or symptoms were observed. 
3. Sporulation Control 
Ten fold dilutions upto 8 .,..ere made in normal Galin e 
:) 
and the tubes were placed at ?CC for 30 minutes to eliminate vegeta~ 
c. 
tive batlli. Pour plate method was ·. employed for the estimation 
of Viable spore count. Nutrient ager was use<i. a.verag~ sp?re count 
~as 10 million spore per ml. 
The Anthrax spore vaccine could not be tested in sheep/ 
goat due to non availability e . ~ th<· same !l.t the morn en t. 
0-pini on 1 
~-- ,· . / ': ,. r .. ·( ,,. ) . '
( . '· 
,}. ·' P.·f 
The vaccine sample is free from any cont::imination and 
proved quite safe :·.n l b 'o. animals. The averap;e sporP. 
count ia · 10 milli~Vi spe:re p e r ml. 
;J!J,,----i 1r<.. . 
f'..-fh ,' 
(D R. HASHOOQ ALI) 
SRO (BP) . 
· for Di rt;!c tor ,, 
$A 
APPENDIX 3 
PANVAC ESTIMATE FOR A COMPLETE 
OFFICIAL CONTROL OF ONE ANTHRAX 
VACCINE BATCH 
52 
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P•t African Veterinary Vaccine Centre (P 
D*az.tt, ~ Tll l'M..nlOOl 
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DEs 1 Dr B.M. Seek . 
I Comelier Technique Principal. PANV AC 
I 




En reponse ajvo1 l me~ fax relatift au sujet susmeationne, j' · 1·hoimeur de porter~ 
votr~sttenti<f que le coUt de ce contr61e.4'eleve ! 700 dollars US (Sept cent dollars US}. Ce 
c:ontrOle courrecd lea tests suivants : . . . 
• lpurete, 
• identite 
• /' pui11ance (deoombrement des spores) 
• 1Moa1ite . 
• ! et eflicacit6. 
I 
Veuillez •r· cher coll¥te, l'expRission de mes~meill[ sent nts. 
~BMS. . 
I : . . 
I 
I : cc: ! . \ 















gred for safety and simple operation 
for freeze drying biological and 
' aceutical preparations 
an average laboratory bench 
ulyocaters for a range of requirements found in 
-\es and industrial plants. Although intended 
or freeze drying the Madu/yo is equally suited to 
uum duties such as evaporation and distillation. The 
· ists of a functional cabinet containing air-cooled 
or compressor, condenser chamber and control 
condenser chamber made from corrosion 
' inless steel is thermally insulated and acts as a 
ater or other solvent vapour; the large flange 
"' flows easy inspection, cleaning and water 
g;The valved drain at the front of the unit facilitating 
rople removal of condensate. An vacuum pipeline 
the chamber to a 16mm o.d. tube on the front panel, 
Chthe E2M5 is connected. A thermocouple meter is 
m?icate condenser temperature during operation. 
:'.t : 
aesigned to fit on the average bench is supplied 
with an Edwards RV5 pump, EMF10 filter and 
·on kit. For operation on 220-240V 50Hz. 
180 







8 Flask drying 
accessory EDWARDS 
This eight port manifold, suitable 
for use with the Madu/yo is ideal 
for applications requiring 
external flask drying. 
Constructed from stainless steel 
with eight welded ports each with 
single neoprene valve. Supplied 
with 8 neoprene cones, 
permitting connection to the 
ports of 8 x 1 litre round bottom 
or flat bottom flasks (flask 
supplied separately) . Dimensions h xo.d. 336x215mm, port 
diameter 19mm. 
Cat No. 402/1050/02 
Each £801 .SON 
Flasks, round bottom, Ouickfit, borosilicate glass, short 
neck, 1 litre. Pack of 2. 
Cat No. 244/0900/79 
Pack £22.630 
Flasks, flat bottom, Ouicldit, borosilicate glass, short neck, 
1 litre. Pack of 2. 
Cat No~i.44/1000/72 
• urJ"~ v::·• 
_;;lei ' '.;1 . 
. ~.q\-1l~~ c..;.ll:\.0-:1. :.. .,;i'"., ,, , :; • 
Pack £23.520 
Series vertical laminar flow cabinets, built to 855295 
I, offer virtually total protection to biological and other 
ucts. This is ensured by the constant and automatically 
. tained airflow and by the 60% frontal outflow. 
f ofthe airflow is recycled which prolongs filter life and 
,lmises the quantity of air blown towards the user while 
ieving the required level of product security. 
series cabinets have the following features as standard : 
Automatic speed compensation 
Airflow indicator 
Elapsed hour counter 
D.O.P. test outlet 
Brighter 
The cool, powerful lamps (1,000 lux) with an output close to 
daylight supply glare-free light. This is diffused by the 3 white 
chamber walls eliminating harsh reflections. 
Quieter 
The oversized blower permits automatic compensation for a 
gradually blocking filter. As a result the noise level remains 
well below the required standards, right up to the time when 









>99.999% for particles >0.3µm 
<allowed by 655295 Class I 




Fine 1818 stainless steel 
Cold rolled sheet steel 1.5mm Epoxy coated 
inside & outside 
Specifications & Ordering Information 
Model L9 L12 
Internal dim's 965x630x760 1270x630x760 
(wx d x h),mm 
External dim's 1085 x 630 1390x630 
(wx d x h),mm x1385 x1385 
Weight 105kg 135kg 
Cal No. 210/0910 /02 /04 ~~·\ ·~1tr..£ · 1. 
Each £4775.38N £so44.s2N 
4
• • - - • • 
\ 
Options & Accessories 
Description Cat. No:Hl~~~~~f~ Each 
Plumbing for gas CO, 310/0710/20 .;ni~ .. s:... £148.00N 
Vacuum valve 310/0710/22 ~~· £148.00N 
Power socket 310/0710/24 .h"ll~ l £118.00N 
Support stand 310/0710/26 . )fT.llli: £369.00N 
Front enclosure 310/0710/28 i· £306.00N 
UV Front enclosure 310/0710/30 ·,~,t<;~1 £443.00N 
Nylon coated benchtop 31°i>/071'o/32',.~J:.W\!,W £233.00N ,._-.. ,:-
Auto light & blower 310/0710/3{ 
. .,.-....: 
£492.00N •: ... 
Adjustable foot rest 310/0710/38-. ,. ··.~:· ' . - • II'. ·• £105.00N 
The price of the Jouan laminar flow cabinets includes delivery from Jou an Ltd. to the customers goods in area. 
you require siting and installation at the point of use, please contact Jouan Ltd. on 011.~ 9447989. 

P' ~ 
Zeiss Standard 25 ICS Microscope 
systems 
~tandard 25 microscope stand with binocular tube, right 
~and mechanical stage, 18mm FOY eyepieces, dust cover, 
~onversion filter and lamp. 
Objectives must be ordered separately, see below. 
Erio:.316/1201100 _. __ _ 
Each £1210.00N ;x 
~ 
(:PAchromatobjectlves, 5x, 10x, 40x and 100x oil, 
'Lrightfield condenser and immersion oil. 
31.i{f~f;._;: .,·-·_:J~~:~ 
.. ..-;:au- £630.00N X · 
;J 
anlCSobjectlves, 5x, 10x, 40x and 100x oil, brightfield 
.Censer and immersion oil. 
201 fiT-' · 
-ua.::-.~: .... n .r;..t.;.,C .• 
£1197.01N 
st outfit with turret condenser and CP 
. objectives, 10x Ph1, 40x Ph2and100x oil Ph3. 
· 'with phase telescope, interference green filter and 
9~oil. 
..,., -,.,, -r 
Standard 25 microscope stand with trlnocular tube for 
video or photography, right hand mechanical stage, 20mm 
FOV eyepieces, dust cover, conversion filter and lamp. 
Objectives must be ordered separately, see below. 
Cat. No. 316/1201/02 
Each £2186.00N 
Simple phase contrast outfit with CP Achromat objectives 
10x brightfield, 40x Ph2 and 100x brightfield oil. Includes 




Simple phase contrast outfit with A-plan objectives, 10x 
brightfield, 20x Ph2 and 40x Ph2, phase stop, phase 
telescope and interference filter 
Cat No. 316/1201/20 
......... - ! .-.. .•. .lo- .. 
··v· r· •: 
t!Ji·t.. ., • 
.. ' ... .:..~J~-- ....... ;.:;;z . .• - .. 
Each £1041.00N 
Phase contrast outfit with turret condenser and A-plan 
objectives, 10x Ph1, 40x Ph2and100x oil Ph3. Complete 
with phase condenser, phase telescope, interference green 
filter and immersion oil. 
--~~f9Qi<?Y~ 
Each 
Polarising outfit. Polarising disc and analyser/lambda plate. 
i ..1"0~~-t' ... ·:If. ., .... ,,,~ ... ow~· t·~· · .C' W't':'.'l'-• ... ,,_ . \;8L 11/28 .. - ~"'.Gi. \;h.~,~~" '• ~ .;.i,..._,,.'!i·!-·l' 
t :.u.-.. ..n..-._' • •. ~ -~ .. , ... :" ·~~.t~" : ~ f ~!Ali t·i· 
Each £133.00N 
Spare lamps, 6V, 20W halogen for Standard 25 microscope 
only. Packof3. 
Water filter, jug 
• Filters out inorganic and 
organic contaminants 
• Improves taste, provides 
better sample water and 
virtually eliminates scum 
and chalking 
• Ideal for drinking, plant 
watering, photography, 
food preparation 
ains tap water is poured into the top reservoir. It gravity 
eeds through a replaceable cartridge into the 2 litre pouring 
, ug, ready for use. The filter uses activated carbon and ion-
exchange resins and significantly reduces/removes chlorine, 
itrates, lead, aluminium, mercury, arsenic and cadmium 
salts. Filter efficiency will deteriorate slightly during its life, 
hich is about 90 litres depending upon hardness and 
mpurity level of mains supply. There is a replacement 
ndictor for the filter cartridge. Supplied complete with one 
,lter cartridge Cat. No. 332/0830/10. 
· No. 332/0830/02 ,, 
£21.95N 
, . ~, ... _ .... ., ....... , .. ,--~-..,.,.. 
.o. 332/0830/10 -, . ""' ~~!··~:-.·;;!· -~,-;-~ · 
-.. -y ::~ 
• · .... ~ •· - .... . IL.' . .. .:· ..J 
£4.SON 
Waterfilter, tap fitting 
• Easily installed and 
removed - no special 
fittings needed 
Operating on the same principle 
as the water jug Cat. No. 
332/0830/02, this completely 
portable unit is simply pushed 
onto the mains tap outlet (range 
of adapters provided), allowing a 
continuous flow of treated water 
to be dispensed. The unit, which 
can simply be moved from one 
location to another, has an 
effective life of approximately 2400 litres, depending upon 
input water quality. When exhausted the filter is discarded. 
EN~33210840/o0"--·--.-•n~• •• --,,- -. _, _ 
Each · £12:88J 
Deionisers, two stage, 
24R 
• Low cost deionised water 
• Assured water quality with 
integral conductivity meter 
• Easy regeneration by the 
operator 
• Robust construction for 
long life 
The 24R is a two stage deioniser 
which will produce a typical 
treated water quality of 15-30µs/ 
cm at flow rates of up to 
400 litres/hour. The unit has been specifically designed to 
give low running costs and ease of operation. Manually 
operated, robust in !=Onstruction and simple to use. The 
integral conductivity meter (powered by a 9 volt PP3 battery, 
included), monitors water quality and indicates when 
regeneration is required. Regeneration is easily carried out by 
flushing hydrochloric acid through the cation exchange resin, 
and sodium hydroxide through the anion exchange resin. 
Typical application areas include:- laboratories, chemical 
dilution, PCB electronics and semiconductors, component 
working and milling, toiletries and cosmetics. 
Model 24R 
Max. treatment flow 4001/h 
Min. treatment flow 601/h 
Max. working temp 35•c 
Min. working temp 15•c 
Max. working pressure 7bar 
Min. working pressure 1.5bar 
Regeneration 
100% pearl/flake caustic soda (Sodium Hydroxide) 1.2kg 
30% w/w caustic soda (Sodium Hydroxide, preferred) 2.71 
46% w/w caustic soda (Sodium Hydroxide) 1.751 
32% w/w hydrochloric acid 3.51 
Effluent volume per regen. 400I 
Max. flow per regeneration 7001/h 
Regeneration time 90min 
Dimensions, overall 430 x 1050 x 360 
Mass, overall working 45kg 
Cat No. 332/0930/04 ._'{:: Zl:p I 
~ .. {I} .. .. ~' . .. ·- .. .,., ,,, .. ~ ..,..._ Each £2391.49N 
• Values can be displa yed in Siemens, Mohms, TDS 
and Salinity (ppm NaCl) 
• Bi-directional RS232 interface 
• Sealed push button control panel 
• Quick and easy to calibrate 
The model 4320 is a user friendly research conductivity meter 
including the features of the 4310 but wi th a LCD graphic 
display. This prompts the user with pla in language 
instructions and structured menu's wh ich allows easy access 
to features with single key strokes. Conductivity values can 
be displayed in Siemens or, if you are measuring low 
conductivities such as purified water, Mohm. The reading can 
also be shown in Total Dissolved Solids w hich relate 
conductivity to the concentration of NaCl. A salinity mode can 
also be selected which will display conductivity results in 
ppm of NaCl. The meter can be calibrated at 1, 2 or 3 points on 
standard solutions, see Cat. No. 309 / 0741 /1 6 on page 
4 - 1236 or by reference to the cell constant. A calibrated 
reminder with an interval of 1to999 hours from last 
calibration can be set and the meter can be programmed to 
give a timed printout from 1 second to 1 day by using printer 
Cat. No. 309 / 0116/ 50. Supplied complete with a glass K=1 
cell with built in ATC, Cat. No. 309/ 0126/ 30, Swing arm 
electrode holder and power supply. 
RECOMMENDED OPERATING 
RANGES FOR CONDUCTIVITY 
CELLS 
Approximate conductivity of 
various solutions at 25°C in 
microsiemens/cm 
0.01 0.1 

































0 to 19.995 with X l O Cell 
Oto 1999g I 
Oto20Mohms 
0.001µ5 to 0.015 
0.001mgllto lg I 
0.01Mohms 
= 0.5% =2 d1g1ts 
= 2° .• = 2 digits on Mohm range 
·10to 105 C 
+ 14to+220' F 
O.l ' C/1 F 
=OSC/ = 1 F 
Oto 100 C 





1, 2 or 3 point calibration on 
standard solutions or via cell 
constant adjustment. 
Bi-directional RS 232C 
Analog output wi th adjustable resolution. 
Hi/Lo Alarm outputs open collector. 
0.5A 50Vdc max. 
Electrode platinizing socket applying 10Vac 
0.05Hz 
0· 19.995 , 0-1999g/1 
Calibration reminder with an interval of 1 to 
999 hours last calibration 
Timed prin tout with an interval from 1 second 
to 1 day. 

















. :• CAN'T FIND IT? 
USE.OUR COMPREHENSIVE INDICES 
1.· , , .. .. (BDH) .. 
• Rugged metal case 
• Vertical format- small footprint 
The CM0830 is a simple bench instrument designed for 
routine Q/C applications. Operation is straight forward. 
Housed in a rugged metal case, it offers good protection 
against harsh environments. 
The CMD8500 is a highly specified microprocessor 
controlled bench instrument, designed for both research and 
industrial applications. Both temperature coefficient and cell 
constant may be varied over a wide range. RS232 output 
permits connection to a PC. The instrument is supplied with a 






















0-50°C manual 0-70°C Auto & Manual 
0.9-1 .1 0.05-19.99 
2%/°C Oto 5.00 (x0.01 )%/°C 
< 1% <0.5% 
R5232 
80 x 210 x 280mm, 2kg 80 x 210 x 280mm, 2kg 
110-240V. 50-60Hz, AC 110-240V, 50-60Hz AC 
309/8300/00 309/8500/00 
£349.00N £450.00N 
Conductivity cell, plastic, for use 
with meters 309/8000/00, 309/ 
8000/02, 309/8300/00 and 309/ 
8500/00, K=1 =10%. 
£57.00N 
L4 : ..4.9S :,. .. , ..,~,,.~ MF.RCK .. i.;;:~ ~ 
Conductivity cells, glass calibrated for use with meters 
309/8000/00, 309/8000/02, 309/8300/00 and 309/8500/00 \ 
K=1.0. i 
Conductivity cells, epoxy bodied, for use with meters 




ABS carrying case for meters 309/8000/00 and 309/8000/C 
C8t.-:No.309°!B000/16 - · ~ - ·-- -- - -· · ·1 __ .., __ ~ ,.... r --·L...-- - ... ,,_ . 
Each £50.00N " 
Soft vinyl carrying case for meters 309/8000/00 and 309/ 
8000/02 
cat.-No."3Ct9iaooo118 -.; : ;:-· :· 1· " r· · 
••' 
0




see FLASKS, from page 4 - 498 
Connectors 
see TUBING, pages 4 - 1205 and 4 - 1206 
Containers - see: 
BOTTLES, from page 4 - 106 
JAl~S, from page 4 - 606 
PACKAGING, from page 4 - 757 
SAMPLE COLLECTION, from page 4 - 1019 
Coplln jars 
see HISTOLOGY, page 4 - 562 
Copper and lead analyser 
see ENVIRONMENT AL ANALYSIS, page 4 - 426 
Copper electrode 
see pH METER ELECTRODES, page 4 - 797 
Cord, PTFE, multi -use 
see BENCH PROTECTION, page 4 - 98 
Corks 
see STOPPERS, page 4 - 1099 
Cork rings, 
see BENCH PROTECTION, page 4 - 95 
Correction fluid, Tipp-Ex® 
see OFFICE SUPPLIES, page 4 - 739 
Cotton wool 
see CLEANING, page 4 - 324. 
• Multiple rotor systems available 
• Rapid rotor exchange via AUTO-LOCK 
• Maintenance free induction drive 
• Sealed accessories for Biological Safety 
• 5 personalised memories 
• Only 58d8 at 3,000 rpm 
Whatever type of sample you have to prepare, using blood 
tubes, biological analysis, cytology slides, cell culture, etc., 
the B4i multi-use centrifuges will simplify your work. 
Save time in frequently used routines with the direct recall 
programmes. Press just one key and you're ready to start. 
Short acceleration and braking times {with 5 variable rates), a 
PULSE KEY for short runs and elevated performance (18,000g 
on microtubes). 
Biological Safety 
An end to biological risks when handling your samples. For 
your personal safety, centrifuge the tubes, bottles and 
microplates in total security, with accessories successfully 
tested by C.A.M.R. Porton Down in accordance to IEC 1010-2-
020. 




Dimensions (h x w x d) 
Weight 
Cal No. 220/0102/02 
4.000rpm 
2,880 x g 
4x 200ml 
Ambient 
372 x 400 x 492mm 
40Kg 
£1615.00N 




Microtube Spin Pack 
a&.Jouan 
A Jouan B4i centrifuge complete with 24 x 1.5ml sealed angle 
rotor. 
Cat. No. 220/01 ci2to3: 
£1858.50N f 
General purpose Spin Pack 
Comprising a Jouan B4i centrifuge complete with a swing-
out rotor, four buckets yvith sealing caps; 2 inserts for 3x 15ml 
tubes each and 2 inserts for 1x 50ml conical tubes each. 
Cat. No. 220/0102/04 
i:2331.70N 
• Pre-cool facility 
• 4°Catmaximumspeed 
• CFC free refrigerant 
• Maintenance free induction drive 
Sample protection 
The refrigeration system is designed for intensive use, even 
in a warm laboratory. A pre-cool facility is available in 
addition to 5 acceleration and braking rates for sensitive 
samples. 
Specification 




Dimensions (h x wxd) 
Weight 
Cat. No. 220/0102/05 
Each 
AUTO-LOCK 
In less than 5 seconds you can 
install any one of the eight rotors, 
thanks to the patented AUTO-
LOCK system. This allows the B4i 
series to combine the function of 
several units for the price of one. 
4,100rpm 
3,026 x g 
4 x 200ml 
-9°C to +40°C 
375 x 575 x 605mm 
72kg 
£2880.00N 






A Jouan BR4i centrifuge complete with 24 x 1.5ml sealed 
angle rotor. 
Cat. No. 220/0102/06 
Each £2843.75N 
General purpose COLDSpinPack 
Comprising a Jouan BR4i centrifuge complete with a swing-
out rotor, four buckets with sealing caps; 2 inserts for 3x15ml 
tubes each and 2 inserts for 1x50ml conical tubes each. 
Cat. No. 220/0102/07 
£3506.SON 
B4i swing-out rotors & accessories 
Description Capacity Total no. tubes 
540 Swing-out Rotor 4X200ml 
Standard Buckets 200ml 
**Sealing Caps 
PP bottle with cap 
Inserts 6x1 .5ml-2ml 24 
Inserts 12X3-5ml 48 
Inserts 12x5ml open 48 
Inserts 6x5-6ml 24 
Inserts 5x5-7ml 20 
Inserts 5xZ5,5ml 20 
Inserts 5XZ10,10ml 20 
Inserts 5x10ml 20 
Inserts 3X 12ml 12 
Inserts 7X15ml 18 
Inserts 3x 15ml conical 12 
Inserts 3x 20ml 12 
Inserts Universal 1 x25ml Plastic 4 
Inserts Un iversal 1 x 25ml Glass 4 
Inserts 1x 50ml conical 4 
Inserts 1 x50ml 4 
Inserts 1x100ml 4 
Cytobuckets 3xCyto-samples 6 
S20 Swing-out Rotor 6 x Microplates 
including carriers 2x96 well blocks 
**Sealed carriers 2x2 microplates 
Cushion for micro plate 1 x microplate 
Biological Safety 
Look out for the** marking which indicates that the 
centrifuge accessory has been successfully tested for 
biological containment by CAMR, Parton Down. 
Rotors continued on next page 
.;-.-: 
ill!. Jouan 
Guide to swing out accessories 
The B4i series centrifuges require an appropriate rotor for 
operation. 
Note: Buckets and inserts will be required for the swing-out 
rotor option unless otherwise stated. 
Dimensions RPM RCF(xg) Pack qty Cal No. Pack 
057mm 4,100 3,026 1 220/0102/10 £328.00N 
057mm 4,100 3,026 4 220/0102/12 £225.00N 
4 220/0102./.!."l £154.00N 
56.5x 112mm 4,100 3,026 6 220/0102/16 £179.00N 
11 x 3gmm 4,100 3,026 4 220/0102/1 &,,. £78.00N 
012mm 4,100 3,026 4 220/0102/tS::-. £78.00N 
012.5mm 4,100 3,026 4 220/0102/~~ I" £256.00N 
013.5mm 4,100 3,026 4 22oio10212T· £78.00N 
013.5mm 4,100 3,026 4 220/0102/22.;' £78.00N 
17x60mm 4,100 3,026 4 220/01~-' £186.00N 
017x60/105mm 4,100 3,026 4 220101·0212'"'4'~ £369.00N 
016mm 4,100 3,026 4 220/01 cri.fi~~ £78.00N ~ 
017.5mm 4,100 3,026 4 220/0t02/2.~l; £369.00N 
017mm 4,100 3,026 4 220/01 <>ii2,7 ': £78.00N 
17 x 122mm 4,100 3,026 4 220/010212ri \.. £156.00N 
022mm 4,100 3,026 4 220(0102/297 £78.00N 
25x85mm 4,100 3,026 4 22Q/01 pi/~~- £266.00N 
29x85mm 4,100 3,026 4 ~l~~ Pi?!-~ .fJI · £186.00N - ,, .. 
30x116mm 4,100 3,026 4 220/0102/32 £256.00N 
033mm 4,100 3,026 4 220/0102/33 £78.00N 
045mm 4,100 3,026 4 220/0102/34 £78.00N 
4,100 2,218 2 22,0/~.1021~- £433.00N 
..... 
3,000 1.157 1 220/0102/45 £488.00N 
i ~ .. -\\, , 
3,000 1, 157 2 220/0102/47 £270.00N 
1 220/0102/49 £35.00N 
SM sterilizers 
• Unique rib heating system provides excellent 
uniformity of temperature in chamber 
• All stainless steel construction - easy to clean and 
corrosion resistant 
Temperature range 30 to 220°C 
• Fitted with 0 to 24 hour timer for automatic process 
operation 
• LED digital display shows actual working 
temperature 
MemmertSM sterilizers are ideal for hot air processing of 
glassware, media, instruments, etc, and the rapid heating 
cycle with timer ensures reliable and swift sterilization. 
The radiant rib construction of the chamber, with all-round 
heaters and full insulation, provides excellent temperature 
performance, variation being below ±4.5°C. 
Specifications and ordering information 
Capacity, litres 
Dimensions (wxd x h), mm 
Internal 
External 
Number of shelf supports fitted 
Max load per shelf, kg 
Power rating, W 
Mass,k~ 











I ~·· -.f(4.~l..- ~ 
£539.61V 
LTE CUSTOMISED THERMAL PRODUCTS 
.~" ._ . 
• Quality products tailor-made to your specification 
• Technical consultation and design by LTE 
specialists r 
• Drawing packages for approval 
• Installation and testing facilities 
If you feel that your needs cannot be met by a 
modified standard product then our customer 
designed service can help. We will liaise with you 
and LTE's Technical Department to produce a 
specification for a suitable custom built pr~duct. 
Included within the Customised Thermal ~r99ucts ·: 
are Walk-in Rooms, Production Dry Heat.Sterilizers .. :, 
and Flame proof Ovens. The specifications for these 
products are well defined, control systems are often 
standard, but the size is usually variable. 
For general enquiries regarding the Customised 
Thermal Products service, please contact our 
Customer Service Centre on 0800 22-33-44 
(Fax 01455 558586). 
200 
32 
Heaters are fully encased, protecting them against a~; ... 
moisture. Control is by means of a mechanical thermo · 
(fluctuation ±1.1°C) with overtemperature protection to 
12880 standards. All models are supplied with two stain 
steel shelves, and the mains cable is fitted with a UK 13A · 





















·, ·~~g - ~·:· 
",.' .. ~~: ~[ ~ .. ~~. 
£650.24V 
Stevenson screen 
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For timing periods from 1 to 60 
minutes. Setting the interval 
winds the mechanism. Alarm 
sounds when timing period has 
elapsed. Dimensions 60 x 60 x 
35mm. 
~ ·~~°" .... ""' . ~~ ·, .. ·.,J:.-~;}'-;: ... ~ ··r-· 
Timer, countdown 
Time is set by centre knob up to a 
maximum of two hours. Timing 
period over when alarm sounds. 
Start button is green, stop is red, 
90mm diameter dial, black with 
luminous spots. Silver-finish 
metal case with black base. 
Overall size; 127x103x68mm, 
mass380g. 
· r:rnaqqrr.r~:lar: : . 
.. 1wt~~~v~c.:rr , 
Timer, interval, key 
wind 
• Big, 90mm diameter dial 
• Separate minute and 
second hands 
• Individual buttons for stop 
start and zero 
Graduated Oto 60 with two large sweep hands, one for 
minutes and one for seconds. Start button is green, stop is 
fed, zero button is black. Silver finish 90mm dial with black 
/Tletal case and base. Overall size, 128x 103 x 58mm; mass 
p20g. 
~.i:iMi0oso. VOO-G:: :-;- 'f .. :• ~'. ~~- .;:::~·-
 ::;-_;;. ·,"9L ...... -- ·~· 11· - ·a;....'b ~ 





• Jewelled lever movement 
• Push button operation 
Records up to 60 minutes, giving 
a reading in minutes, seconds 
and fifths of a second. 16 jewelled 
lever movement with side hand 
re-set button. Encased in a 





_ .. !:;:;.:· ... : . .;.~j y· ·1·M E RS /~ i .. /~;~ 
. -;.1~·1i·. - ~ ~ .... • t:.. .. . • '"'~ 
.._..... ....... ~-·wt •. "\-- - ,._ 
Timer, countdown 
This timer has a maximum 
setting of 99 minutes and 59 
seconds, and counts down in 1 
second increments. At 0.00 a 
beeping alarm sounds for 30 
seconds or until the timer is 
turned off. The countdown is 
stored for repeat timings. 
Incorporates a magnetic 
attachment on the back. Battery 
included. 
£10.42J 
Timer, countdown to 
100minutes 
A simple inexpensive countdown 
only timer with single memory 
and zero time alarm. Clear 10mm 
LCD with 3 button control for 
setting minutes and seconds, 
start/stop, clear and memory. 
Magnetic back clip and stand. 






count up, clock 
• Easy numeric setting 
• Last setting memory 
• AM/PM selection 
Clock with single timer and count-up functions to 9hr 59min. 
Times can be quickly and easily set by direct numeric input 
rather than having to use multi-function buttons. Unit can be 
hand held stood on the desktop or adhered to a metal 
surface u;ing the built-in magnet. Supplied complete with 
battery. 





Auto start and stop for true one handed operation 
Continuous or intermitent operation 
'nique soft rubber cup for tubes up to 30mm dia. 
. hree alternative shaking heads included 
bust variable speed model with speed electronically 
rolled and adjustable from 20 to 2200rpm. Orbital 
ement of 4.5mm and a special setting for microtitre 
1tes. Supplied complete with microtitre platform, soft 
Jber platform for flasks or beakers up to 250ml and 
ersal platform. Overall dimensions (wxd x h) 
c240x60mm, weight 3.5kg. For operation on 230V, 
160Hz. 
!llllP:r33 /0378/02 i.,r -~, ~1- I 
llllili)'.o v !. ').·.-.1 ~ '": • 
£234.SON 
:essories and spares for MS1 shaker IKA 
• • • 
·~· ·: ... . .  .. 
~ 4 • • 
":' . : ~· 
• 
·• • • • .. . 
·-..:..:. ·~ !., . .d)' 
1dard attachment, (1) supporting plate for tubes, 
.imum diameter 30mm. 
0. 333/0378/00 
.. ~, -
-....;...:..· .. .. L ..... 
£5.00N 
e hand attachment, (3) supporting plate for beakers and 
1<s. 
~333 ... ,. 11 .. -;;'•··_.-
~~ Ii' /03~8~ '· ;-; {'J~jf,,:;_ ··s::-, ..... -:; ..... 
h £9.22N 








~("J!{Qll ll · £17.23N 
. ~t~f!J't\1~ £8.41 N 
Test tube attachment support 
Cal No. 333/0378/12 
Each £6.39N 
Microtitre plate attachment, (2) for 85 x 130mm plates. 
Cal No. 333/0378/14 · . .. .,.. ~ . .. . · ·. 
•hM:.·. r .... _.::C•\-. -.JI/''£• ... ~~--- .. ----- _r .. , 
Each £15.20N 
One hand insert for use with Cat. No. 333/ 0378/ 12. 
Cat. No. 333/0378/16 
Each £2.94N 
Shaker/mixer, Mini MS2 
The MS2 is the same shaker unit as the MS1 but without the 
microtitre plate option and attachments . 
Cal No. 330/0378/04 
Each 
~ .. ~ . . 
£209.10N 
• Automatic start and stop for one-handed operation 
• Variable and fixed speed models 
Robust, vibration-free and quiet shakers which have a unique 
rubber cup to allow shaking of tubes inside the cup and larger 
tubes, and even small bottles, on the outside. One model is 
fixed speed, the other has a recessed wheel for changing the 
speed located atthe bottom of the front fascia. Both models 
have on/off switches at the rear to give these shakers a clean 
modern appearance. For operation on 220/240V, 50Hz 
supply. 
Speed 
Dimensions, h x w x d 
Weight 
Fixed Variable 
·-:. ... i~ ~ :'. ,; 
.,_. ' 




PT series square-pan 
sartorius 
• Compact size 
• Light and easy to carry 
• Fast, stable display 
• Battery power option 
The PT portable series balances are small, light, compact and 
easy to carry which means that they really live up to their 
name and are ideally suited to those applications where you 
have to weigh on the move or away from a permanent 
laboratory setting. In fact, if you fit 
the optional internal rechargeable 
battery pack, you can literally use 
the balance anywhere at a 
moments notice. This makes them 
suitable for biological field work, 
warehouse inventory checking 
and trading standards work. There 
are three models from a tenth of a 
gram to one gram readability, and 
610g to 6.1kg capacities. As a natural addition to their mobile 
personality there is a carrying case available as an optional 
accessory. 
Specifications 
Model PT1500 PT3100 PT6 
Capacity 15009 31009 61009 
Readability 0.1g 0.1g 1g 
Pan size 174x133mm 174x133mm 174x133mm 
Type _. .Si.ng~~ r<m.ge _ Single range Sirygl~ range_ 
C~.No. 303/~~· ~· L02i-1i ,,t«:i·, - /12.~" .. :r \..- ~~11-rii ~;'~.:. 
E~·;h . . ... . :. ,' £465.00V £595.00V £385.00V 
\ 
l\ccessories for PT series portable balances 
:arrying case, suitable for all PT models. 
_c~N_o~3~¥@!.j~~J ~~ ~ r-~L _ ~~tJ '!~;;:!_l.j·?~~~~f: 
:ach £138.00V 
BALANCES 
PT series round-pan 
• Compact size 
• Light and easy to carry 
• Fast, stable display 
• Battery power option 
Nearly every type of Sartorius balance can be quite easily 
transported. There is no need to lock the mechanism and on 
arrival at the new site connect to the mains supply and allow 
some time to temperature equilibrate. The PT portable series 
balances make it even easier to do mobile weighing. They are 
small, light, compact and easy to carry which means thatthey 
really live up to their name and are ideally suited to those 
applications where you have to weigh on the move or away 
from a permanent laboratory setting. In fact, if you fit the 
optional internal rechargeable battery pack you can literally 
use the balance anywhere at a moments notice. This makes 
them suitable for biological field work, warehouse inventory 
checking and trading standards work. There are four models 
from a hundredth of a gram to one gram readability, and 150 
to 610g capacities. As a natural addition to their mobile 
personality there is a carrying case available as an optional 
accessory. 
Specifications 
Model PT150 PT310 PT600 
Capacity 1509 3109 600g 
Readability 0.01g 0.01g 0.1g 
Pan diameter 116mm 116mm 116mm 
Typ.~ -· ·- -----~ ?ingle _r:~~ge .. , .:>lngle_r_arig~,.-- Single range 
Cat. No. 303/4006 /.® ;" 01 .,.. ~ , ./1,4, I ;,i_: )_?_i.i~ 198:~-;;,: ... ;~:-
- - · ' ·'-'-·- · .. . ~ 
Each £445.00V £495.00V £385.00V 
Battery pack, rechargeable, for use with any PT model. 
Thermostatic water bath/circulators, W Series 
Excellent stability, ±0.004°C 
Wide temperature range 0° to 150°C 
Pump for external circulation 
fitted as standard 
Exceptional temperature 
uniformity throughout the bath 
The W series of precision baths form part of a comprehensive 
selection of thermostatic products from Grant Instruments. 
They are available in five tank sizes with a choice of digital or 
analogue control units. Baths are complimented by a range of 
useful accessories. 
Designed for precision 
Every bath is fitted with an electronic temperature control 
system, using Pt 1000 temperature sensors. The most 
significant feature of the control system is its unsurpassed 
long-term stability. 
The circulation system maintains a high degree of 
temperature uniformity throughout the bath. A propeller 
forces liquid down below the control unit, under a circulation 
tray, and up at the far end. This produces a powerful 
horizontal flow throughout the whole of the working space, 
which is much less affected by objects in its path than 
conventional pump stirring. 
Note: 6-litre (W6) baths are not fitted with a circulation tray 
because good uniformity can be maintained throughout the 
small working space by the impeller alone. 
Baths 
The five baths in the range include 38-litre, 28-litre, 22-litre 
and 14-litre tanks, plus a 6-litre model intended primarily as a 
small circulator for pumping temperature-controlled liquid 
round other apparatus. 
Baths have stainless steel tanks with outer cases offibre-
reinforced plastic. Lifting handles are recessed into the ends 
of the baths. Straightforward instructions are printed clearly 
on the outside of the baths. 
Specifications and ordering Information 
Control units 
Control units have an injection-moulded case for 
components, with heater, pump, stirrer and temperature 
sensor projecting downwards into the liquid. The control unit 
of a 6-litre bath is mounted on a stainless steel cover over the 
tank, while those for larger models fit over one end of the 
bath. 
There is a choice of two control systems, analogue or digital. 
The analogue system has a conventional knob and dial, with 
knob lock, and a screwdriver-operated control for fine 
adjustment over a band of 2°C. The digital system is available 
at very little extra cost. To set the temperature, the knob is !~, : "' 
pushed in and turned until the required temperature appeant 
on the digital display. Once the knob is released, the set - "· 
temperature cannot be accidentally altered and the display - ~ ·• 
shows the actual liquid temperature. Controls on both -
systems are recessed, and control units can be easily ' ~ 
detached for cleaning or servicing. 
The pump allows any bath to be used for circulating 
temperature-controlled liquid round other apparatus. 
Grant model No. W6-KD W6-KA W14-ZD W14-ZA W22-ZD W22-ZA W28-ZD W28-ZA W38-ZD 
Digital Analogue Digita l Analogue Digital Ana logue Digital Analogue Digital 
LCD LCD LCD LCD LCD 
0.1 0.1 0.1 0.1 0.1 
Temperature range ( 1). °C Oto 150 Oto 150 Oto150 - 30to + 150 Oto 150 
Stability, °C 0.004 0.004 0.004 0.004 
Uniformity, °C ±0.01 :!:0.01 ±0.02 :!:0.02 
Tank capacity, litres 6 14 22 28 
Tank dimensions, I x w x d, mm 300 x 150 x 150 325 x 300 x 150 505 x 300 x 150 505 x 300 x 200 
Top opening, l x w 120 x 145 210 x 300 390 x 300 390 x 300 
Liquid depth, mini max, (2) mm 80 / 140 70/ 130 70 / 130 120/ 180 
Overall dimensions, l x w , mm 330 x 180 350 x 325 530 x 325 530 x 325 
heightto tank rim, mm 175 175 225 225 
overall height, mm 365 270 320 320 
Pump, max head, metres 1.7 1.7 1.7 1.7 
max flow, water, l / min 8.5 8.5 8.5 8.5 
Safety protection, temperature adj . cutout adj . cutout adj . cutout adj. cutout 
level float switch float switch float switch float switch 
Heater power at 220-240V, kW 1.4 1.4 1.4 1.4 
Overall consumption at 220-240V, 
kW 1.5 1.5 1.5 1.5 
/02 /04 /12 /14 /16 ·.\-:. /18 /22 /24 
~ ._ .. •--. - ..... "" .. ....... . -. ·-·· .. ....... 
£734.00V £625.00V £729.00V £620.00V £776.00V £667.00V £782.00V £673.00V 
Notes: 
(1) With accessory cooling below room temperatures. See page 4 - 85 for cooler units. 
(2) Maximum depth can be increased by 10mm by removing the circulation tray in 14, 22, 28 and 38-litre baths, with slight loss of performance. 
4 -.74" .. . . ·,,. : .· . ... \ MERCK):·~~, x "' • ~ · • • ~ • u v.· • ,;o:-# . llio , .. .. , .,;_. 
CHROMACOL CRIMP CAPPING SYSTEMS 
The Crimpmate benchtop crimper has a unique lever action 
which greatly reduces the effort needed to produce a 
perfectly crimped vial. The quaUty of the seal can be 
reproduced every time, speeding the process and avoiding 
muscle fatigue for the operator. 
Chromacol hand crimpers are fitted with hardened steel 
jaws to prolong their working life. They have an adjustable 
stop to give reproducible crimp pressure. The 8 mm 
crimper features a centring device to locate the smaller vials 
to the correct position. 
rampmate wor k t f s a ion 
Jaw Size Chromaco/ No. CaLNo; · Each 
.. ' 
Without jaws CMS-0 372/500-0/00 £373.00N 
8mmjaws CMS-8 ~72tS000/08 £519.00N 
11 mmjaws CMS-11 372/500-0/11 £519.00N 
13mmjaws CMS-13 372/500-0/13 £519.00N 
20mmjaws CMS-20 37'.2/500-0/20 £519.00N ' 
nm pm ate 1aw set 
Jaw Size Chromacol No. Cal No.-- Each 
8mmjaws CMJ-8 372/5100/08 £156.00N 
11 mmjaws CMJ-11 ~~~i~j:l?9tJ_1 £148.00N 
13mm jaws CMJ-13 37i/5100/13 £148.00N 
20mmjaws CMJ-20 372/5100/20 £148.00N 
Crimp mate d ecapper 1aws 
Jaw Size Chromacol No. Cat.No. Each 
8mmjaws CDJ-8 372/5110/08 £158.00N 
11 mmjaws CDJ-11 372/5110/11 £162.00N 
20mmjaws CDJ-20 372/5110/20 £193.00N 
. r ... 
rf 
/. 
Hand crim ers 
Jaw Size Chrot/lllCO/ No. 
8mmjaws CR-8 




Dec a ers 
Jaw Size Chromacol No. 
8mmmouth DCR-8 





Jaw Size Chromacol No. 
8 mm jaws DCB-8 
11 mmjaws DCB-11 
20 mm jaws DCB-20 
Vial tra s 
Description 
Holds 10 
22mm dia. vials 
Holds 15 
12mm dia. vials 
Holds 15 
6-8mm dia. vials 
SCI-RAK, Aluminium 
210 x 134mm 
Holds 104 vials w ith 
12mm o.d. by 32mm 
SCI -RAK 
Aluminium 
Holds 180 vials 













See page 4 - 959 
in the Safety Sectio~.: 
of this catalogue. 
A small powerful magnetic stirrer without heating, for 
volumes up to 800ml. Variable speed from 0 to 
1500rpm. White surface is ideal for titrations. 
Overall dimensions, wx d x h, 115x130 x 44mm. 
Working surface area 115x130mm. Weight 0.23kg. 
Suitable for operation on 80-230V, 50/60Hz. 
• - -- - ~~ ... ,,.~,,. •:r- " ..... - • ~-~- ..... ; 
Cal No. 333/0276/00 ·f ·~J!~V-' : . ~ .. · ·' ·-~~t.fi i · 
Each £83.00N 
Magnetic stirrer, KM0-2 basic 
A small powerful magnetic stirrer with stainless steel 
housing. For volumes up to 5 litres. Variable speed up to 
1100rpm. 
Overall dimensions, wxd x h, 140x200x75mm, weight 
1.7kg. Enclosure to IP21(DIN40050). Suitable for operation on 
230V,50Hz. 
Cal No. 333/0253/00 
£173.00N 








Cal No. · · 
Each 
Hl-190M 
Magnetic stirrers, · 
mini · 
• Low cost stirrers, 1 "3 
litre capacity ·-:, .. :. 
• Variable speed ~~ 
control 1l· 
High quality magnetic s~rr 
with variable speed contr31 
choice of either 1 litre or 2.5 
capacity. Low cost Hl-190M 
plastic cover which will res' 
harmful effects of chemical$ 
accidently spilled. 2 year ~ 








~~0230/o2 .- , -~~~~ij),L _ _,.,,~-i'i. -~ 
£53.53V £82.25V 






• Constant rpm even 
viscosity changes 
• Optoelectric speetl 
~ 
. ' 
\'.. ~t. . 
·'?>.'{.' 
A variable speed stirrer up to a maximum 1100rpm: ~ 
The optoelectronic speed control continually mon1to.!' 
and actual speed, ensuring constant rpm during anY. 
in viscosity up to 1000mPa/sec. Maximum stirring ~o 
20 litres (for fluids of low viscosity). Overall dimens!o 
(w x d x h) are 155 x 235 x 118mm, weight 2.4 kg. · 
Cat. No. 333/0282/00 
Each £249.00N 
' 
STIRRING BARS (FOLLOWERS) 
A range of followers is offered: 
Glass covered bars (Cat. No. 333/0034) are suited to · 
general routine stirring at lower speeds. 
Polypropylene coated bars (Cat. No. 333/0036) are resistant 
to a limited range of chemicals, and suitable for use to 
approximately 130°C. 
PTFE or Teflon have a low coefficient of friction, are 
resistant to almost all chemicals and can be used 
continuously to 260°C, intermittently to 315°C. 
--- !" • 
Size of Size overall, 
magnet, mm mm 
19x3.5 25x6 
24x3.5 30x6 
















Stirring bars, glass 
For use with magnetic stirrers. 
Magnetised core enclosed in 
glass. 
Cal No. •:+:., Eachfor10 
'\" ~~~~·;r.~:~t/.;"' . 







For use with magnetic stirrers. 
















• Ideal for mixing in small 
volume containers 
Microsize. Magnetised core in Teflon TFE case. For mixing in 
small containers, vials, testtubes etc. Autoclavable. 
Excellent chemical resistance, withstands temperatures up to 
2so0 c. 
Dia. x length, mm N.Ref 
2x7 6610-0207 
3x10 6610-0310 










Cal No. Each for to Each 
333/0035/01 £4.44 £5.00R 
333/0035/02 £4.74 £5.34R 
Stirring bars, PTFE 
For use with magnetic stirrers . 
Immune from leaks or weak 
spots. All sizes offer the 
advantage of the centre spinning 
ring. Powerful magnetic core. 
Cal No. Each 
333/0041/01 £0.BSJ 
333/0041 /02 £0.BBJ 
333/0041/03 £1.21J 
333/0041 /04 £1.61J 
333/0041 /05 £2.36J 
333/0041 /06 £3.46J 























Stirring bars, egg 
shape 
;; 
An elliptical magnet is enca' 
a seamless Teflon coating.-
stability at high speeds in ro 
bottom flasks orvessels. ' 
Length, Diameter, For flask 























- ·~.-_:~~ ' ' . . Stirring bar, PTFE~ triangular " 
Particularly effective for ·'' 
dissolving solids and m~ 
sediments because ofth' 
scraper-like action on th 
of the container. 






Cat No. ,.l .. ._ ~.,. t-: .  r.~ 
333/0049/02 :."':~· · ·: £0.94P 
333/0049/04 ·' ( £1.23P 




• Fins for superior mix 
• Outstanding chem!c 
resistance ' 
Magnetic stirrers with rr.' 
magnetised core in Teflo 
case. Autoclavable. 0 . 
chemical resistance, use. 
260°C. Symmetrical stirring fins at top and bottom f~r~ 
superior agitation. Develops a strong mixing vortex~ 
low stirring speed in flat or round bottom vessels. 
1
.I 
Oia. x ht, mm N.Ref. Cal No. 
10 x 8 6600-0010 
14 x 12 6600-0014 
17 x 13 6600-0017 
22 x 15 6600-0022 
30 x 12 6600-0030 
35 x.12 6600-0035 
40 X14 6600-0040 
58 x 15 6600-0058 
Flow Vacuum Pressure 
l/min mbarABS mm Hg Bar 
20 60 715 1.0 
20 15 748 
1.0 
38 60 715 
, contains diaphragm valves and seals 





Charles Austen chemically resistant all PTFE portable oil-free 
diaphragm pumps for laboratory benchtop use. With all the 
contact parts in solid PTFE and PVDF connectors they are 
ideal for use with corrosive gases and vapours in the most 
demanding appl ications including gel drying and distillation. 
Compact and lightweight with a convenient carry handle they 
are easy to maintain and service. Model SEP is a single 
headed pump, while the double headed version DEP can be 
parallel or series connected at choice (see performance 
details below). 
Dimensions Max c8t.t.io:;~ . Each 
·mm kg ... t~t:r:~:~!- . 
195X130 X230 5.5 326/0197/00 £427.67N 
~~~~~,. 
250 x 130 x 285 6.5 326/0197/02' £727.39N . '· • ' ' .· .. 
_ACUUM/PRESSURE DIAPHRAGM PUMPS, KNF 
gm pumps 100% oil free for vacuum or pressure. 
1se levels, maintenance-free, suitable for bench top 
e laboratory and for continuous operation. 
f 
. odel N022AN.18. This pump has an aluminium head 
eoprene diaphragm and stainless steel valves. Fitted 
rrying handle, rubberfeet, on/offswitch and 2m 
cable with plug. Inlet/outlet tubes 6mm OD. For 
·on on 230V, 50Hz. 
lcauon 
!" 
ite 0.9m' /hr (151/min) 
P 100mbar 
re 4bar 
Sfons (w x d x h) 230x 145x 190mm 
-
"·<r. -~·---i:.~"'"'-~~~"!ll[ ~"' 1"""'-8/0127/M.,.,;:;, . • ~tt·':-~-:rr: ,;~1,;;-.1•, ~i· ~~$..,,±;.-.: 
. '"'~'6.~.:t?~ .. - .~ '.ll.4.-i& . ~- iA!..""!... 
£335.44N 
Typical applications include: 
• Membrane filtration 
• Vacuum moulding 
•Aeration 
• Assisted filtration techniques 
Pump, diaphragm 
KNFModel N035AN.18. This pump has an aluminium head 
with neoprene diaphragm. Fitted with carrying handle, 
rubber feet, on/off switch and 2m mains cable. Outlettubes 
9mm OD. For operation on 240V, 50Hz. 
Specification 
Flow rate 1.68m'/ hr (28 f/min) 
Vacuum 100mbar 
Pressure 4bar 







As Cat. No. 218/0181 but with 
adjustable permanent pilot flame 
and main burner controlled by a 
positive action lever operated 
valve in the base. Cannot accept 
flame spreader. 
·.cat No:.2fat01Bt/ocp ;, :: ;-i-~h'iu~~q{; ...- ~,.,. ~.T.:t ,. s"'+' 




Micro pattern with air and gas 
regulator and normal size nozzle 
for 6.5mm rubber tubing. Plated 
brass tube, base finished in 
acrylic gloss paint. Outside 
diameter of tube 5mm. 
Bunsen burner, LPG 
Fine tolerance jet with regulator. 
Inlet tube 10mm, outlet 12.5mm 
diam. For flame spreader see Cat. 
No. 218/0675i 00 page 4 - 162. 
Cat No. 218/042S/OO ·:~;.._' , .·l~;_ 
..... l..·*··I~ • .-" ... ~£-..• 
Each £6.71J 
Gauzes - see page 4 - 543 
Mats - see BENCH PROTECTION, page 4 - 95 
Triangles and Tripods - see STANDS, page 4-1077 
AMAL BURNERS 
Burner, natural gas 
Amal Minor. Diameter of head 
25mm, height 133mm, mounted 
on a round base with carrying 
handle. 
Burner, natural gas 
'' .Amal Major. Diameter of head 
· 43mm, height 180mm, mounted 




:catNo."21810210/00" ·'_ .!· : · -~ · 't, ~·~·< 
'.:.. ~ . . -... · . ., ·~ . 
Each £66.70J 
·Burner, natural gas 
Amal Maxim us 3-Jet. Diameter of 
head 69mm, ovenill height 
185mm, mounted on a round 
base with carrying handle. 
APPENDIX 5 
COST EST/MA TION FOR THE VETERINARY 
VACCINES LABORATORY - KABUL 
2110711998- ICRC 
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f;;Cof (,,-(__ / {(_o 0 
~. ~-- j t:~ - l(.//.,AP(! 
F- \jo&fl. Jt.ifb . 
THE ANIMAL & HUSBANDRY VACCINES LAB ORA TORY - KABUL 
REHABILITATION WORK - COST ESTIMATION 
Kabul 21 .07. 1998 
100. Masonry : 
a) - to fill with the brick existing door-way : dim. 195 x 250 cm x 40 cm ----------------------
b) - to open a new door-way : dim. 100 x 208cm - -----------------------
c) - cement plaster of the art. a, b, and d : dim. 22.0 m2 ------------------------
d) - to close with the brick shower partition: dim. 4.5 m2 (thick. 12 cm)----------------~------
100.0 $ 
200. Carpentry: 
e) - new inter. wooden cellular-core door : dim. I 00 x 208 cm - pc 1 - -----------------------
f) - to create a spy- window in exist. doors : dim. 20 x20 cm - pc 8 - -------------··----------. 
g) - to build in the exist. niche a cupboard 
in hardboard, with 4 doors & shelves 
h) - to glaze in the window & door block 
: dim. 120 x 250 cm - pc 5 - -------------------------
: dim. m2 -------------------------
300. Painting : 
i) - oil paint on wall & window : dim. 
j) - white wash with 50% plastic paint 
on wall & ceiling - rooms 3 to 6 : dim. 
400. Floor finishing : 
k) - to lay a linoleum in rooms 6 to 11 
and in the corridor 
500. Electrical installations : 
I) - to install double neon lighting 
600.Sanitary installations : 
: dim. 
m) - sanitary installations in the laboratory 
n) - sanitary installation - exterieur work - septic tank 
)1/l 












INVENTORY OF THE EXISTING 
CHEMICALS AND EQUIPMENTS IN THE 
LABORATORY OF KABUL 
77 
INVENTORY LIST OF CHEMJCALS IN THE VET VACCINE PRODUCTION 
SUPPORTED BY ICRC. 
No Name of thechemicals Amount Remarks 
1 Magnesium chloride 500gms. 
2 Amoniam sulphate lkg 
3 Potassium dichromate lkg 
4 Lactalbomine hydrolysate lib 
5 Nutrient agar 2lbs 
6 Briliant crystal blue l Ogrns 
7 Agar 500grns 
8 Thiomersal lOOgrns 
9 Potassium iodide 500gms 
10 McConky agar base llb 
11 Oil immersion lOOml 
12 Phenol red 25gms 
13 Crystal violet lOOgms 
14 Safranin 25 gms 
15 Methlene blue 25grns 
16 Bactone peptone 2lbs 
17 Tryptose blood agar base 3lbs 
18 Saponin lkg 
19 Pyrogalol 200gms 
20 Saponin white 500gms 
21 Purified agar lOOgms 
22 Geimsa stain 25grns 
23 Methyl violet lOgms 
24 Chloral hydrate 500gms 
25 Lablemco 500gms 
26 Complement fixation test tablets lOOgms 
27 Eosin 25 gms 
28 Maltose 500gms 
29 Phenol lkg 
30 Sod chloride lkg 
31 Saboraud,s dextrosea.gar 500gms 
32 Peptone 500gms 
..,.., 
Natriumdihydrogen phosphate !kg .) .) 
34 Potassium dihydrogen phosphate 500gms 
35 Di natrium hydrogen phosphate lkg 
36 Sod. sulphate 500gms 
37 Sod.azide IOOgms 
38 Glucose 3kgs 
39 Phenol liquid 2 liters 
40 Ditto! 3 liters 
41 Sulfuric acid 2.5 liters 
42 Forrnaline 6liters 
INVENTORY LIST OF THE INSTRUMENTS AV AlLABLE lN VET VACCINE 
PRODUCTION SUPPORTED BY ICRC. 
No Name of the instrument Number Used for 
1 Autoclave( medium) one 25 years 
2 Portable Autoclaves two I 0 years 
3 Hot air oven( medium) one 20 years 
4 Water Distillation machine one l year 
5 Water boiler one I year 
6 Printing machine one 26 years 
7 Incubator one >30years 
8 Incubator one 7 years 
9 Capping machine one one year 
10 Compound microscope one 7 years 
11 Refrigerator one 5 years 
12 Electric balance one l years 
13 Mechanicyl balance one 5 years 
14 Electric sterilisator two I 5years 
15 Mechanical balance(small ) one 5years 
APPENDIX 7 
PROTOCOLS OF PRODUCTION OF 
BACTERIAL VACCINES IN KABUL 
81 
PROTOCOL FOR PRODUCTION OF 
ANTHRAX SPORE V ACCJNE IN 
MINISTRY OF AGRICULTURE LABORATORY 
SUPPORTED BY ICRC KABUL 
1. An ampoule of a valid vaccine strain (steme strain 34f2) is aseptically broken. The 
content is dissolved with sterile Nutrient Broth (NB) which again is mixed aseptically. 
Then subcultured in NB, Nutrient agar(NA) Blood Agar(BA), Robertson,s cooked meat 
media, and Sabouraud,s dextrose agar. Beside that a smear is made for Gram' s 
staining. 
Media are incubated over night (0/N). Smear is examined for percentage of spore, 
vegetative and possible contamination. 
2. The incubated media is checked for characteristic growth of strain the nex1 day. A 
Motility test is also conducted on NB culture. 
3. A sub culture is made from NB to NA plate and is incubated QIN.The growth in plate 
is examined under low power of microscope for characteristic Medusa head growth. 
Then three colonies are selected of which smear is made from with in the colony. The 
colony which shows the sign of sporolation is selected for subculture. 
4. The seed culture is made in a flask of nutrient broth the size of which depend on the 
number of Roux flask of nutrient agar prepared for mass culture, sterilised and 
incubated O/N. The broth is examined for purity. 
5. The Roux flasks containing NA, PH 7.2 prepared a day before are seeded with 2 ml of 
inoculum. Incubated for 96 hours at 37°. Then it is taken out of incubator and kept at 
dark room temperature for 72 hours . 
6. The growth after being examined physically and microscopically is harvested in 
Merthiolet saline (Harvest). The harvest is examined for purity and percentage of 
sporolation. The rate of sporolation must >95 %. Merthiolet saline consist of: 
-Distilled water One liter. 
-Sod.chloride five grams. 
-Merthiolet 0.05gm. 
Note: Saline is sterilised first, Then Merthiolet is added infront of flame. 
7. The harvest is further incubated O/N. Thereafter it is kept at +4°c. 
8. The harvest is shaken for 5-10 mins. every day until 21 st. day. 
9. On 7th day after thorough shaking by hand, one millilitre of the concentrate (harvest) 
is diluted in 4 ml of sterile Normal saline(NS). Then two adult Guinea pigs, weighing 
about 300-350 grams are injected by S/c route with 0.5 ml of the suspension. They 
are observed for 5-7 days . There should not be any untoward reaction. 
10. Step(9) is repeated on 14th day. 
11 . On 21 st day a spore count is conducted. 
12. Based on the Number of spore I ml of concentrate, saponin saline is calculated. 
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This is sterilised in 12 lc0 at 15 pound for 40 minutes. 
13 . In front of the flame the required amount of concentrate is added to saponin saline to 
adjust the spore content at the level of 10000000 I ml. 
14. The vaccine is dispe sed in bottles of 50 ml. 
15. Sterility of the vaccine is conducted by: 
-Physical appearance. 
-By smearing from the vaccine. 
-Final spore count, to have the required amount of spore per ml. Overages 
added to make for the loss during transportation and storage. 
-Inoculation to Nutrient media like: Nutrient agar, Nutrient broth, Blood agar. 
Robertson' s cooked meat media, and Subouraud,s dextrose agar. Incubated 
for five days m 37c0 and room temperature respectively. No contamination 
should be observed. 
SAFETY TEST: 
1. The safety of this vac ine is conducted in three unvaccinated sheep, bought from the 
market before being vaccinated. The sheep are reared thereafter in the premises of 
vaccine production itself until use. 
2. The selected animals for the test is under observation three days before inoculation. 
The temperature is recorded morning and evening. 
,., 
.) . With all necessary precautions, The sheep are inoculated an amount of 0.5, 1.0, and 
5.0 ml S/C. The temperature of animals are recorded morning and evening. 
There should not be big changes except for a slight rise of general temperature 
and slight swelling and lameness for a day or two. The temperature is recorded 
for 15 days. 
The dose for this vaccine is 0.5 ml for sheep and 1.0 ml for cattle, route of inoculation SIC, 
expiry- one year after manufacture, Keeping temperature at +4-8c0 , To be shaken well 
before inoculation, annual repeated inoculation is needed. 
ECONOMIC STUDY: For preparation 100 ml concentrate 
1. Requirement (media)for seed culture 
2. Media for mass culture 
3. Merthiolet 
4. Saponin 
5. Distilled water 



















13 . Cold chain 
14. G1 ass ware 
15. Equipment 
TOTAL 
100 ml concentrate will give 40000 doses. 
472000 divided by 40000= 12 AFS . 




472000 AFS/1 OOml concentrate. 
The nearest counterpart for our vaccine is Pakistani Anthrax vaccine which costs Rs.53/1 00 
doses. The vaccine produced in ICRC supported vet vaccine production is approximately 
1200 Afs I 100 doses . This is equivalent to about 1.5 Pakistani Rupees. The Uraguay 
manufactured vaccine is costing 1.7 USD for each 100 doses. 
The selling price would be to match the market price. 
Table of comparison of cost /dose of various vaccines from diffirent manufacturers. 
Each USD equals 42000 Afs. 
Indicator: 
1. kv (Kabul vaccines). 
2. pv (Pakistani vaccines) . 
3. ov (Other vaccines). 
BEST REGARDS 
VET AND HUSB TEAM 
ENTEROTOXAEMIA VACCINE 
AND ITS ECONOMIC STUDY 
Strain used : Cl.welchi Type D. 
The vaccine is produce as follows: 
Seed culture : A highly toxigenic strain of Cl. welchi type D I. V.R.l lndia. 
Method of Production: 
Medium used: 
The equal parts of Beef and liver infusion is adjusted to PH 9.6 while hot. Steamed for ten 
minutes in steam steriliser. It is filtered clear and to the clear filterate is added 2 % 
bacterialogical peptone and the PH is readjusted to PH 8.2. 
Chemically pure sodium chloride to a final concentration of 0.5 % is now added and the 
medium is buffered with 0.4 % dibasic potassium phosphate(k2HP04). 
The medium is sterilised in running steam for about 45 minutes on each of three consecutive 
days. Ferrnentable sugarin the form of dextrose to a final concentration of not more 0.2 % is 
added at the time of inoculation of the production flasks with young (5 hours growth) 
actively growing culture of Cl.welchi type D in a similar medium. An increase in 
concentration dextrose up to o.5 % in the seed medium for growing seed culture for 
inoculation in to the product10n flasks will be beneficial.The production flasks are cooled to 
37c0 on 3rd day after sterilisation just before inoculation. The bulk of inoculwn in the seed 
medium of actively grov.ring culture should be between 2-3 % of the medium contained in 
each of the production flasks . 
Active growth with large gas production, starts wtith in about three hours of inoculation and 
continues as such for a time up to about 6-8 hours. Growth stops by about 24 hours after 
which the flasks are removed and tested for purity and aerobic sterility by microscopical and 
cultural examinations. 
The PH of the product at this stage is almost usually neutral. About five ml of the product 
from each flasks is removed asepticall and pooled for testing mice. Atleast two mice each is 
inoculated IN with 0.2 ml of the ctear centrifuged product(pooled sample) and they usually 
die with in about 8-24 hours . 
A good quality trypsin(merck) is added to the production flasks( after removal of the sample 
for testing the mice) to a final concentration of 0.25 %and mixed thoroughly with the culture 
and the flasks are again incubated at 37c0 for one and half hours. Two ml of the product is 
removed again , pooled and centrifuged. 
The clear supernatant is injected I/V in a dose of 0.01-0. J ml in to mice. That will kill mice 
with in a short time indicating that the epsilon toxin present in the product in the form of 
protoxin before the treatment with trypsin, has now been converted to epsilon toxin. 
Dilutions are made, using sterile nonnal saline with the pooled bacteria free clear toxinand 
the lethal dose per ml of the product is determined. This varies from 1000.8000 mouse 
mld/ml depending upon the type of animal from which the meat and liver is collected for 
media preperation, quality of peptone used, variation in the bacterial population in the seed 
and production flasks and also quality of trypsin used for activation etc. 
Immediately after removal of production flasks from incubator after activation with trypsin. 
the product is pooled ans formalised to the concentration of 0.5 %and incubated at 37c0 till 
the product become atoxic to the mice in a dose of 0.2 ml I/V, this period has been found to 
be from l 1-18 days. 
The product is bottled in sterile bottles with aseptic precautions infront of flame, stoppered 
with sterile rubber corksand kept in l-5c0 till tested for sterility, safety, ans potency and 
issued. 
Sterility Test: 
Random samples are tested for sterility by inoculating a sample of product in aerobic 
anaerobic media and observed for five days kept inthe incubator at 37c0 all the time. 
Safety test: 
At least eight sheep and or 12 Rabbits (depending upon the availibility of the animals) are 
used for testing the safety test and potency of each brew of vaccine. Two sheep each recieved 
S/c 10 ml and the other six sheep each recieves 2.5 ml s/c of the product. The Rabbits are 
each given s/c a dose of five ml. Their morning and evening temperature are recorded for at 
least five days. During this period they show no systemic reaction and only a minimum of 
local reaction. 
The sheep recieving 10 ml doses are discontinued from experiment after five days .Each of 
the other other six sheep are inoculated with a second dose of 2.5 ml of the same products 
not earlier than 14 days after the reciept of first inoculation. 
MA TE RIALS USED ON PRODUCTION OF ONE LITER OF 
ENTEROTOXEAMIA VACCINE 
Material Amount AFS/cost 
1. Distilled water 1000 ml 500 
2. Liver 250 gms 12000 
3. lean beef 250grns 10000 
4. Peptone 10gms 10000 
5. Potassium dihydrogen 
ortho phosphate 4gms 10000 
6. Sodium chloride 5gms 1000 
7. Sodium thioglycholate lgrn 1000 
8. Dextrose 10gms 1000 











10. Different media used 
for testing and growth 
of organism. Qty.sufficient 2000 0.05 
11. Salary 150000 150000 3.25 
12. Electricity and water 
charges 6000 6000 0.15 
13 . Large and small ex-
-perimental animals 20000 20000 0.45 
14. Transportation 10000 10000 0.25 
15 . Stationary and comrnuni-
-cation charges. 5000 5000 0.1 
16. Wear out of the 
building. 5000 5000 0.1 
Total AFS for one liter 245000 5.0 
One 1 it er of Enterotoxeamia gives 1 OOO doses. 
One dose costs Afs.245. 
One 50 ml bottle costs Afs 12250 That equals= I 6.5 Pak.RS. 
The cost for each 50 doses of Uruguay manufactured Enterotoxeamia vaccine purchased by 
F AO is 1.164 USO and each dose costs 960 Afs. 
'· 
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PROTOCOL FOR PRODUCTION OF 
BLACK LEG VACCINE AND ITS 
ECONOMIC STUDY 
1. Composition: 
Organism Source Strain Properties 
Cl.chovoie. IVRI no.49 50 % 
Cl.septicum. IVRI no.51 50 % 
2. The organism intended forBQand Malignant oedema vaccines production are examined 
microscopically and culturally for evidence of aerobic contamination. Biochemicl and 
animal inoculation tests are made annually or more frequently . If necessary organism 
used is to conform to classification in Bergey,s Manual of determinative Bacteriology. 
3. The purity of the organism is detennined by microscopic examination . The virulence of 
the organism is maintained by passage through susceptible animals, e .g.Guinea Pigs. 
4. Medium for seed culture: 
1. The medium used for growing the seed culture shall consist of : 
Distilled water(DW) 1 OOO ml. 
Liver tissue 250gms. 
Muscle tissue 250 gms. 
Peptone 10 ms. 
Potassium hydrogen phosphate 
( dibasic) 4 gms. 
Sodium chloride 5 gms. 
Sodium thioglycholate l gm. 
Dextrose 10 gms. 
* Grind the meat finely and boil in DW for 15 minutes until thoroughly cooked. Filter 
through muslin cloth to remove the meat particles and disolve the chemicals in the filtrate . 
* Heat to just below the boiling point and adjust the PH to 8.2-8.4. 
* Filter through filter disks or by some other suitable method and distribute the filtrate in to 
cotton stoppered large tubes or small flasks. These tube or flasks may contain one inch of the 
residue, if desired. 
* Sterilise in the autoclave at 15 pound pressure for 20 minutes. 
* Medium not used with in 24 hours after sterilisation is heated to drive off absorbed 
oxygen, cooled to 37c0 and immediately plated. Medium older than seven days is discarded. 
MEDIUM FOR CULTURE: 
The media used for production of the vaccine shall consist of liver-muscle-chemical bouillon 







Potassium hydrogen phosphate 
250 gms. 
10 ms. 
( dibasic) 4 gms. 
Sodium chloride 5 gms. 
Sodium thioglycholate 1 gm. 
* Procedure of grinding, boiling, filteration and filling in to the flask of 3-5 liters or bigger 
bottles e.g 20 liter bottles. 
* Sterilise in the autoclave at 15 pound for 30 minutes and incubated over night at 37c0 . 
* The production flask may be planted upon cooling at 37c0 or restored in the incubator and 
planted the following day. Medium not planted with in 24 hours of sterilisation is not to 
be used. 
* At the time of planting the production flasks sufficient sterile 50% Glucose solution is 
added to the medium to make a final concentration of 0.5 %. The glucose solution is 
prepared as follows: 
DW 10000 ml. 
Glucose 500 grns. 
Bring it to a boil and transfer aseptically to a presterilised cotton stoppered flasks or tubes. 
* Inoculation of production media is carried out as follows: 
(a)At least two daily transfers are made from the stock culture prior to inoculating the 
production flasks, incubation of the seed matteria\ may be prolonged to 48 hours, if necessary 
to obtain satisfactory growth. 
(b) The inoculation of the fl.ask containing the production medium is accomplished by 
directly transferring the content , at least 100 m 1 of the seed culture in to the production 
flasks under the flame of bw1sen burner in a closed room. 
( c) Each strain of the organism is grovm separately and only tubes showing good f,'TOwth are 
used as seed culture. 
* The production flask ar grown at 3 7c0 for a period of 3-5 days or until good growth is 
obtained. 
* The product is prepared as follows : 
(a)After the production culture have been incubated for the required period the flasks are 
removed from the incubator and a microscopic examination made on samples taken from 
each. Those showing contamination or suspecious atypical growth are heat sterilised and 
discarded. 
(b )Flasks found to be satisfactory are vigorously shaken and the growth is strained 
through sterile gauze in to a graduated cylinder and subsequently transferred to a mixing co-
-tainer. 
(c)Equal volume of Cl.chauvoei and Cl.septicwn are combined in mixing container. 
(d)A sufficient amount of 10 % formalin saline solution prepared by adding 100 ml of 
stock(35-40 %) formaldehyde solution to 900 ml of sterile distilled water is added to the 
culture combinatiorn to yield a concentration of 0.5 % formalin by volume in the product. 
(e)The product is thoroughly mixed and may be bottled immediatly or pennitted to stand 
at room temerature for 24-96 hours before filling in to the containers. 
* The product is not standardised by nephelometry or bacterial count. 
* The preservative consist of 0.5 % formaline by volume. 
* The batch of serial number is ascertained at the time of formalisation. The average 
volume of the serial is 15000 ml. 
The following tests are conducted on the finished products : 
(1) Sterility test: A sterlity test is conducted on the finished product from 3 % (not to exceed 
10) of the final containers by inoculating 0.5 ml and 1 ml of the productin to each of two 
tubes containing the following media : 
Nutrien broth, Blood agar, Nutrien agar, Robertson,s cooked meat media and suboraud,s 
dextrose agar. 
Batches of vaccine found to contain living bacteria may be held in at room temperature or 
37c0 incubator for 24-96 hours, after which period a retest is conducted. 
Potencv test: 
At least six susceptible Guinea pigs shall be inoculated with 3 ml of the product. Fourteen 
days later, at least three of the vaccinated animals to either with two control will be 
challanged with Cl.chauvoei and the remaing three or more vaccnated animals together with 
two controls will be chalanged with Cl.septicum. All the control animals should die with in 
96- l 44hours, while the vaccinated animals should all survive. 
Safety test : 
The vaccinated animals used for potency test will will suffice for safety test. These animals 
should remain well during thier vaccination period. 
All tests are to be completed and recorded before any of the product is released for 
distribution and use. All batches or portions thereof on which satisfactory tests are not 
obtained are to be discarded in such a manner as to be safe. 
* The product is prepared in liquid form only and is filled into 50, 300, and 500 ml bottles. 
The bottles are sealed with sterile rubber skirt stoppers. 
* An expiration date of one year is given. calculated from the earliest date of harvest of the 
production culture obtained in the batch, provided the product is stored in the dark at a 
temperature below 45 t'° . 
* The product is recommended for the prevention of black quarter (Cl.chauvoei ) and 
malegnant oedema(Cl.septicum)infections in cattle and other ruminants.The recommended 
dose is 5ml for calves of all ages and 2-3 ml to sheep and goats. 
MATERIALS USED ON PRODUCTION OF ONE LITER OF 
BLACK QUARTER AND MALIGNANT OEDEMA VACCINE 
Material Amount AFS/cost USD/cost 
1. Distilled water 1000 ml 500 0.01 
2. Liver 250 gms 12000 0.3 
.... lean beef 250gms 10000 0.2 -' . 
4. Peptone 10gms 10000 0.2 
5. Potassium di hydrogen 
ortho phosphate 4gms 10000 0.2 
6. Sodium chloride 5gms 1000 0.025 
7. Sodium thioglycholate lgm 1000 0.025 
8. Dextrose 10gms 1000 0.025 
9. Sodium hydroxide Qty.sufficient 1000 0.025 
10. Different media used 
for testing and growth 
of organism. Qty.sufficient 2000 0.05 
11. Salary 150000 150000 3.25 
12. Electricity and water 
charges 6000 6000 0.15 
13. Large and small ex-
-perimental animals 20000 20000 0.45 
14. Transportation 10000 10000 0.25 
15. Stationary and communi-
-cation charges. 5000 5000 0.1 
16. Wear out of the 
building. 5000 5000 0.1 
Total AFS for one liter 245000 5.0 
One liter equals to 333doses 
One dose equals=405Afs 
One 50 ml bottle costs Rs.30. 
Each 300ml Pakistani BQ vaccine which is equal to 60 doses costs Rs.62.28. Thereby each 
dose costs 882 Afs . 
The Uraguay manufactured vaccine costs 900 Afs I dose. 
Note : BQ vaccine produced by MADERA produces immunity against Black leg disease 
only but the BQ vaccine produced by ICRC supported Lab produces immunity against 
Malignant oedema also . 
BEST REGARDS 
VET AND HUSB TEAM 
PROTOCOL OF PRODUCTION OF HEAMORRHAGIC SEPTICEAMIA 
DENSE SUSPENSION BACTRINE 
1. Passage of strain every 15 days by I/P route in mice. Organism harvested from the 
heart of injected mouse and maintained in blood agar(BA) in +4 ° .Annex-1. 
2. Testing of the colony by slide agglutination test against antiserum for formation of 
fl oculati on( floculati on test) . 
3. A single colony of Pasteurella multocida on BA is selected and transfered to a 
Nutrient broth(NB) test tube(Annex-2). 
4. The 18 hours growth of NB is transfered to a 500 ml NB flask after testing by Gram 
stammg. 
5. The 18 hours broth culture after test for purity is transfered to a 10 1 iters broth for 
mass culture and incubated over night. 
6. The growth is formalised by formaldehyde at the rate of 0.5 %. 
7. The turbidity of the dense suspension harvest is adjusted to tube No.7 of Brown,s 
Opacity tubes. If needed diluted is diluted with formalinised saline. 
8. The PH is adjusted to 6.5 and hot 20 % solution of Potash alum added to give a 
final 1 % alum. 
9. After over night(O/N) storage with agitation the vaccine is bottled for use in the 
field. 
The following tests are conducted on the bactrine: 
A. Sterility test. 
B. Safety test. 
Sterility test: 
1. By smear after Gram staining. No other organism should be observed, live or dead. 
2. On media. 
The following media are used in this lab for sterility testing so far; 
-B 1 ood agar. 
-Nutrient agar. 
-Robertsons,s cooked meat media. 
- Saboraud,s dextrose agar. 
Sterility test is conducted for five day. ln this case no growth of any kind should be observed. 
Sometimes as a counter chick a further sub culture of Robertson,s cooked meat media is done 
and maintaine for another five days. Again there should not be any growth. 
Safetv test: 
This test is so far conducted on Rabbits only. That is, three adult, unvaccinated, healthy 
Rabbits are taken. Vaccine is given to them by S/c route on the buttock. One Rabbit \vill 
recieve 5 ml, second one will recieve 2.5 ml of vaccine. The third will act as control. 
These animals will be observed for 10 days. There should not be any kind of untowards 
reaction. 
To confirm protective effect : 
Fifty mice are injected I/M with 0.2 ml of vaccine on day zero and day 14.0n day 21 they are 
divided in to 10 groups of five each being challanged with dilutions of 6-8 hours broth 
culture of field strain in the range of I 0-1 to 10-10 dilutions. 
Fifty other unvaccinated mice are also challenged similarly. They are observed for 5 days. 
The MLD can then be calculated. 
A protection of 2 Log unit in the vaccinated mice is an indication of sufficient protection for 
cattle. 
Duration of immunity : 
A dose of 3 ml of vaccine i calves 4-8 months old provide immunity of 6-9 months. A 
booster is required 3-6 months later. Thereafter an annual booster is needed. 
ECONOMIC STUDY: (for one liter, Dense suspension culture bactrin) 
No Item Amount 
1. Lean beef One kg 
2. Pepton 20gms 
3. Sod.chloride 5.0gms 
4. Glucose 5.0gms 
5. Electricity 
6. Water 









Each liter of this vaccine give 330 doses 
Each dose costs Afs.669.0. 
One 50 ml bottle costs 10715 Afs 
One 50 ml bottle costs Rs.12.60 

















The nearest counterpart to our HS vaccine is Pakistani vaccine. Each bottle of this vaccine of 
300ml costs Rs.62 .28, and for each dose costs 882 Afs. 
The other vaccine is Lelystat vaccine. One I 00 dose of this vaccine costs 6. 9 USO. 
93 
Anthrax spore vaccine 12 450 714 
2 Black quarter vaccine 405 
3 Enterotoxeamia vaccine 245 
4 Heamorrhagic septiceamia vaccine 669 882 2,900 
5 Sheep pox vaccine 4 450 2,180 
6 Fowl pox vaccine 14 
7 Newcastle vaccine 10 1,144 






VET AND HUSB TEAM. 
APPENDIX 8 
PROTOCOLS OF PRODUCTION OF VIRAL 
VACCINES IN KABUL 
95 
NDV vaccines: 
PROTOCOL FOR PRODUCTION OF 
NEWCASTLE DISEASE VACCINES 
AND ITS ECONOMIC STUDY 
-Newcastle BI. 
-Newcastle LA SOT A. 
-Newcastle K. 
METHOD OF PRODUCTION: 
-Chick embryo method. 
1. Procurement of fertile , fresh eggs from a form that gauranties 80 % fertility with the least 
record of mortality in the farm . 
2. After following necessary procedures and arranging to keep the eggs in incubator, the 
eggs are kept in incubator. The incubator is tested 24 hours before being used. It is made 
sure that the temperature and relative humidity(R.H) is accordingly adjusted.It is then 
fumi gated. The eggs are incubated for nine days . 
3. While observing and recording the temperature and R.H, the eggs are shaken 3-5 times 
every day.the eggs are examined (candled) on fifth day. lnfertle eggs are discarded. 
4. On the ninth day the eggs are candled again and the living embryoes are confirmed. 
5. Air sac of fertile eggs(embryo) marked. With the necessary precaution and aseptic 
condition Intra allantoic inoculation is performed. 
6. Seed culture is prepared. That is a 1:100 of the seed ampule is prepared in sterile normal 
saline, where upon to every ml of the seed 400 l.U of penicillin and one mg of 
Streptomycine is added. 
7. To every embryo 0.1 ml is inoculated and the hole is covered by solid paraffin. 
8. The embryoes are incubated again.Those embryoes dying with in 24hours of incubation is 
taken as nonspecific death and are discarded. 
9. The remaining embryoes that die until 96 hours are collected. They are to be kept in +4c0 
for about 6-10 hours or over night( O/N). 
1 O.The air sac of embryoes meant to be harvested is cleaned with povidon solution or tinture 
of iodine. 
11.It is then separated by the he! p of a sterile scissors. 
12.The allantoic fluid is exposed systematicallyand the fluid (the vaccine) is collected in a 
sterile container. 
13. From every container sample is collected for Heamagglutination test(HA titration). 
TESTING OF THE VACCINE: 
The sterility test is conducted in : 
1. Nutrient Agar. 
2. Nutrient Broth. 
3. Blood Agar. 
4. Robertson,s cooked meat media. 
5. Subouraud,s dextrose agar (room temperature ). 
The are kept at 37c0 and in room teperature for five days. No growth of any son should be 
observed. 
ST ABrLITY AND EID50 of the vaccine is also tested, but not in regular basis but once or 
twice in a year. HA test is done regularly for every batch that is produced. This test is done 
on 
l % washed chicken RBC. 
SAFETY TEST: 
This test is done on poultry.????????? 
DISPENSING: 
The ampules in which the vaccine is to be dispensed are printed with necessary information 
on 
vaccine, its use, dose, immunity, expirey, keeping temperature etc is printed on the back of 
the am pule. It is sterilised and under sterile procedures dispensing of vaccine is done. That is 
0.5 ml to each am pule. This is followed by freez drying for 24 hours. Before nicking of the 
am pules the am pules are vac urne tested. If the vaccume is complete then nicking of the 
ampules are done. With all these precautions if again there are some ampules that has 
incomplete vaccume, that particular ampule is discarded. 
Before sending the vaccine once again a sterility test is conducted on the vaccine to make 
sure 
it is double checked. 
The dose for NOV is 
Newcastle B 1 for day old chicks, from a d ilution of one am pule of the vaccine in I 0 
ml normalsaline two drops in eyes or nostril. 
Newcastle LA SOT A for two weeks old chicks, same as above . 
Newcastle K, for three months old and after, 0.5 ml , l/M in chest muscle. This vaccine 
is repeated every 3-6 months. 
ECONOMIC STUDY: FOR 100 ML HARVEST (40000 doses) 
No Item amount Cost/Afs USD 
1 . Strain one 10000 0.25 
2. Fresh, fertile hen eggs. 30 pcs 150000 3.6 
3. Phosphorus pentoxide 100gm 12000 0.26 
4. Penicillin one vial 5000 0.1 
5. Streptomycine one vial 5000 0.] 
6. Nystatine one vial 10000 0.25 
7. Lactose powder 20gms 10000 0.25 
8. Peptone !Ogms 5000 0.1. 
9. Na2Hpo4 !gm 5000 0.1 
10. KH2po4 2gms 10000 0.2 
] 1. Alcohol 75 % lOOml 10000 0.2 
12. Dittol 50 ml 3000 0.06 
13. Povidone 50 ml 3000 0.06 

















Total in AFS. for each 100 ml harvest which gives about 40000 doses of Newcastle vaccine, 
is 378000 AFS divided by 40000 doses equals 9.64 AFS for each doses. 
Australian NOV is costing 2.6 USD for each 100 doses. Each dose of this vaccine costs I 092 
Afghanis . That is about 100 times of vaccine produced by ICRC supported vet vaccine 
production 
No Name of the . \raceme " Cost/dose. .Cost/dose Cost/dose .. 
'· ·of ' of 0·pv(Afs) ofov(~) 
' 
.. :.'~ • ,. 
' I "#' " kv(Afs) -- ~? 
1 Anthrax spore vaccine 12 450 714 
2 Black quarter vaccine 405 
.., 
Enterotoxeamia vaccine 245 ~ 
4 Heamorrhagic septiceamia vaccine 669 
5 Sheep pox vaccine 4 
6 Fowl pox vaccine 14 
7 Newcastle vaccine 10 I, 144 
8 SaLpullorum antigen 4 
Each USD equals 42000 Afs. 
BEST REGARDS 
VET AND HUSB TEAM 
PROTOCOLFORFOWLPOXVACCINE 
PRODUCTION METHOD.:, 
In chick embryo bv CAM method. 
Seed strain from Razi of Iran, and IVRI of India. 
Procurement of eggs are done on the principals followed on NDY. 
1. Egg shell cleaned, incubated at 37c0 and RH of 60 %. The eggs are shaken 3-5 times 
a day and temperature and RH is recorded daily. 
2. On 5-6th day eggs are examined infertile eggs are discarded. 
3. At the day of 1 I-12th all embryos are examined only the living embryos are used for 
production of vaccine. 
4. The air sac area of the embryos are cleaned with antiseptics and marked a triangle in 
an area devoid of blood vessels and near embryo by a marker. The seed culture 
which is already prepared inoculated in specified area. 
5. An ampoule which has no air in an aseptic condition is diluted 1:100 in normal saline 
to which 2000 I. U of penicillin and one mg of streptomycin is added to every ml. 
6. Preparation of egg for inoculation: 
The air sac area of the embryo is cleaned with 75 % Ethyl Alcohol and a triangle is 
drawn in an area near embryo, but devoid of blood vessels. The shell of triangle is 
separated by egg dri ller in such a way that the under lying membrane remains intact. 
At the same time a narrow hole is created on the top of air sac. 
A drop of sterile normal saline is put on CAM by a sterile needle. The air of the air 
sac is drawn by a rubber bulb and an arti fi cial air sac is created under the triangle . 
INOCULATION OF THE SEED: 
From the previously prepared dilution an amount of 0.1 ml is put on created artificial sac and 
the triangle is closed. The hole on the top of air sac is closed with solid paraffin. The 
embryos are incubated again as previously for three days. On 4th day it is taken out and kept 
in +4c0 O/N. 
HARVEST: 
The shell of the egg is cleaned all over with 75 % ethyl alcohol. The shell is opened and 
CAM is harvested. It is to be mentioned that every step in the production is perfonned 
aseptically. 
A sterility test is conducted on harvest. After a satisfactory sterility test, the harvest the CAM 
is triturated by blender and to a ratio of 4:100 PBS (phsphate buffer saline) solution PH 
7.2-7.4 is added. That is 4ml of PBS to I 00 ml of vaccine. Then dispensing in vial is done 
and sent for freeze drying. 
STERILITY TEST: 
Sterility test is conducted as in Newcastle disease vaccine. 
SAFETY TEST: 
A double dilution of the ratio of 1:10, 1:20, 1:40 is prepared. From each dilution 
inoculation 
is made to a susceptible chick of 1-3 months by scarification method. No untoward reaction 
is to be seen. The chick that is inoculared with 1 :40 must show pock formation on the site 
of inoculation for a potent and good quality vaccine. The chicks are observed for 14 days, 
and on 21 st day serum is collected for plate agglutination test with antigen. 















































































Each 100 ml stock gives about 40000 doses of Fowl pox vaccine. 
Each dose cost 14AFS. 
An ampoule of 100 doses costs AFS= l400. 
.-ioo 
N'o' .. Nafue';'-01tfie.'.vaccfue : .. '.;''''":···, .... ·., ·' costid.ose.'. tJoSUd.ose: ...:~Jdose: ... ·· "".;: ·· · 
: ; . ~ ·: ::2:~L::::, ·: ~·;: :,.~ . ·;~~~; ,':· r~:~tt~ ~~l<~~: : ." ~L~::~-. ·· 
1 Anthrax spore vaccine 12 450 714 
2 Black quarter vaccine 405 
3 Enterotoxeamia vaccine 245 
4 Heamorrhagic septiceamia vaccine 669 
5 Sheep pox vaccine 4 
6 Fowl pox vaccine 14 
7 Newcastle vaccine 10 1,144 
8 SaLpullorum antigen 4 
Each USD equals to 42000 Afs. 
Best Regards 




Sheep used : 
PROTOCOLFORSHEEPPOXVACCINE 
AND ECONOMIC STUDY 
Susceptible lamb of 6 months to one year. Before the use of sheep for inoculation 
of the seed the animal is kept under observation for 3-4 days . During this period the body 
temperature of the animal is recorded morning and evening. 
Preparation of sheep for inoculation: 
Both side of the sheep from the area behind the Scapula to the last Rib is shaved, washed 
with soap and disinfected with a suitable disinfectant. 
Seed preparation: 
Four ampoules of the seed virus are dissolved in 120 ml of sterile normal saline for 
inoculation. Each side of the sheep is cleaned with a suitable or available antiseptic. Six 
points in a horizontal with equidistant spaces in between, in two rows is selected and to each 
one 10 ml of seed is inoculated. The temperature of the inoculated sheep are recorded 
morning and evening until it shows the highest temperature. The area of injection is inflamed 
and show local reaction. The recording of temperature is continued until a decline is 
observed in temperature. This will take 5-6 days. Thereafter the sheep is slaughtered. 
Separation or harvest of virus from tissues: 
The tissues and the fluid of the area is separated and collected aseptically in a beaker. 
Trituration of the tissues: 
The tissues are weighed and to the rate of 1/3 sterile serum, sterilised by filtration, is added. 
Then it is triturated by blender. It is then filtered . To each millilitre of the filtrate 2000 I.U 
of Penicillin and 2mgs of Streptomycin is added and kept in refrigerator. 
Internal Quality Testing: 
Sterility testing: 
A sample of the harvest is inoculated to common laboratory media like; Blood agar, Nutrient 
agar, Nutrient broth, Robertson's cooked meat media and subouraud' s dextrose agar at 37c0 
and room temperature for five days. 
Saf etv test: 
From a dilution of 1/10, 1/20, aseptically is inoculated intra dermal in to four points of the 
under side of a susceptible sheep aseptically. The temperature of the sheep is recorded twice 
daily for 15 days. Both sites of inoculation must show reaction, that is by pock formation . 
But no untoward effect is to be observed. After having the assuring result, it is to be 
proceeded for freeze drying. 
The dose for this vaccine is 0.1 ml. 
Diluent- Normal saline. 
Route of inoculation- IID . 
Site of inoculation -Under side of the tail. 
Keeping temperature -20c0 . 
Imm unity- one year. 
ECONOMIC STUDY: 
No. Item Amount 
1. Sheep one. 
2. Feed 
3. Sterility Media 
4. Transport 
5. Alcohol 100 ml 
6. Equipment 
7. Antibiotics one vial each 
8. Sheep for testing 
9. Water 
10. Electricity 



















The result here will be 300 ml of harvest, which will give about 300000 doses. 
Cost of one dose about four Afghanis. 
One ampoule of 200 doses costs 800 Afs. 
The nearest counterpart to our vaccine is Pakistani vaccine whjch costs Rs.50/ 100 doses. By 
this account each dose will cost 425 Afs. 
The next vaccine to compare is Lelystat which costs 5.20 USD/100 doses. Each dose will 
cost about 2184 Afs. 
Anthrax spore vaccine 12 450 714 
2 Black quarter vaccine 405 
3 Enterotoxeamia vaccine 245 
4 Heamorrhagic septiceamia vaccine 669 
5 Sheep pox vaccine 4 450 2,180 
6 Fowl pox vaccine 14 
7 Newcastle vaccine 10 1,144 
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BRIEF REPORT ON THE BACTERIAL 
VACCINES PRODUCTION IN THE MADERA 
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Brief Report 
on bacteria) lhlffinf prt>ducti{)n 
bv rl({ccim: pr{)duaion l11bor1lfNV in j,l/,l/,1b,1d 
Livestock is a major economical component of Afghan farmers and a valuable \\·calth source for 
Afghanistan, which has been seriously affected during the war due to many different causes . One 
or the causes can be total destruction of vaccine production laboratoril!s in Kabul. bringing the 
loss of animals to a maximum. Importation of vaccipe from abroad and its early on and on time 
disposal of vaccines to the farmer due to the lack of transportation. proper storage and other 
factors also were not proofing much effective due to loss of efficacy of the imported vaccines . 
Therefore. MADERA, an organization that which is working for the development of' rural 
economy in Afghanistan, took the initiative to rehabilitate vaccine production laboratories in 
I 1Jl)7 to provide necessary vaccines for the eastern and. to· a certain · extent. central zo1il;s of 
Afghanistan and othe.r working areas . 
1:rom January to the end of August 1997. all necessary conditions such as providing and washing :(o o "" ~ , 
stores. constructions of additional 3 roon1s. purchase of necessary equipments, provision of seed 
culture. purchase of necessary chemi.cals, experiment4l animal and etc were achieved. 
The laboratory was officially inaugurated on November 7. 1997 in the presence of Headquarters 
of MAD ERA, Governor and other high officials of the Eastern Zone, F AO officials and all other 
NGOs · representatives . 
During 1997. the laboratory produced 91200 doses of ETY. which wns successfully used in the 
target areas to cn.mpaign against the diseases during lamming seas.on. 
P reduction of bacterial vaccines for the eastern and central zones, some F AO clinics. some NGOs 
and Jalalabad governm~nt clinics, is shown in the follqwing tables (November 19997-Dccembcr 
I . 
I ll998) : ' . . 
Month Type Qf vaccine ETV 
December 1997 91200 
Vaccines produced in ·1998 (in doses) 
.~ I 
' 
ETV BQY llSV ASV CCPP 
l 
. 
J:u111:in I <10000 - .. ·---
h :bruary --· ---·- - - Undci:_Q~occs~ ~ ~ - procc~~ --- -·- -·-·- --· -----·--
March 95000 4 ()()()() LI . llf<:?_~ess - -----· ·- ·- ---·-- --- - - - ·- · 




Jnh l 1. process l I. p rnccss 
AugLtSI 2 0000 20000 -----. - --- -
Sept cm her U. process . .. I I 7 (100 
·~ 
October 120000 I - --
~O\ ember U. process I I 
December 140000 U. process i 
T oral production 442000 103500 212100 368000 I 160000 
Grand total (doses) qi ?,, .. 00 + 1285600 ::: J <.:r( <i <' C> 
Tora I production of bacterial vaccines in 1997 and 1998 is : 
91200 + 1285000 = 1376800 doses \ 
lks1dcs this_ \\"C have produced concentrati,; for 120000(} qoscs of ASV to be diluted and bottled 
for future use . 
While the original plan for 1998 was one million doses. our production shows more than t\\'ic:e of 
tili..: objeCllVC. 
J:tl:tlabad, Janu:.iry 5, 1999 
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OCD AND AGRICULTURE ORGANIZATION 
tF THE UNITED NATIONS 
PROJECT AFG/96/007 
Livestock Development for Food Security 
in Afghanistan 
_J-J..J - ' • .J~ ~ 
OJ \.:1 \ ~ h I !l\.Jy ~ 
lddress House 8, Str. 30, F-7/, G.P.O.Box 2713, Islamabad, PakiStan Ph. (51) 821517, 821603 Fax 828173 EM afg96007@faopak.msm.cgnetcom 
To: Mr. Rod Charters, ICRC, Kabul, Afghanistan 
8 November 1998 
Ref: 10\kbl'vlab1.wp5 
M. Jean-Francois Cautain, MADERA, Peshawar, Pakistan. 
Vaccine production in Afghanistan 
Further to our recent joint meeting on the above subject I list below our normal annual 
requirements for vaccines that we supply to our VFUs. This will give you an indication. 
of the· types of vaccines that need to be manufactured. 
7 . 
Type of Vaccine Estimated number of doses 
Anttnax 5 eoo OOO J 
Enterotoxaemia 4 OOO OOO 
Blackguarter 1 ,000,000 
Pasteurellosis (Lysopast) • 
Hemorhagic Septemcemia 
Pestes des petit ruminants 
NeWGastle disease in J?Oultry 
{;umbgr=e dise!Jse in poultry 









20 OOO OOO 
•Lysopast" is a trade name for a vaccine manufactured in France that can be used for 
both cattle and sheep (HS and pasteurellosis respectively). 
In addition I would like to confirm that we would strongly support the formation of the 
committee to run the vaccine laboratory in Kabul. As discussed the committee should 
consist of ICRC, MADERA, FAQ, VSA Kabul and a member from the vaccine laboratory. 
It was also agreed that this committee should meet in Kabul on 2nd December 1998. 
With best regards, 
~~'-' 
/, . - / 
Terence J. Barker 
Programme Manager 
AFG/96/007 
C.C.: Dr. A.B. Mehrahban, FAO, Islamabad. 
'AND AGRICULTURE ORGANIZATION 
jHE UNITED NATIONS 
PROJECT AFG/96/007 
Livestock Development for Food Security 
in Afghanistan 
.,,_;J - I • J_?:.-l- ~ 
OJl.~1 ~hi !.lU..P-~ 
ddress House 8, str. 30, F-7/, G.P.O.Box 2713, Islamabad, PakiStan Ph. (51) 821517, 821603 Fax 828173 EM afg96007@faopak.msm.cgnetcom 





8 November 1998 
Ref: 1 O\icrc'athrxv1 . wp5 
This letter is to confirm that FAQ Livestock Development for Food Security Programme 
will support the purchase b~• .the Veterinary Services Association of the Anthrax vaccine 
manufactured in the Kabul :'J'Sccine Laboratory. Since the test results on -samples of this 
anthrax vaccine were satisfactory and because . there is no po5sibility of testing it 
elsewhere at this time, we accept the tests carried out in Peshawar, Pakistan. The 
AnimaltHealth Department, FAQ headquarters in Rome, have supported this view and 
are also willing to accept local test results under the cireumstances. 
· We understood that you have about~ .5 million doses available and we agreed on a 
price of 25 paisa (0.25 Pak Rupees) per dose. 
With best regardt 
/(jJ}5 ~ 
Terence J. Barker 
Programme Manager 
AFG/96/007 
C.C.: Dr. A Majok, Epidemiologist, PAO, Islamabad. 
Dr. AB. Mehrahban, FAQ, Islamabad. 
Dr. A Osmani, FAQ, Islamabad. 
Mo 
. · .. ~·~·.\ ~ ~~·~{~~.:;~~ ··~:· ·~· . · .- • ••• 1. 
APPENDIX 11 
P.P.R. SERO-MONITORING SURVEY IN 
AFGHANISTAN BY F.A.O. (1995-1998) 
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PPR Sero-monitoring in Different Districts of Afghanistan 




A- Nanqarhar Province G- Zabul Province 
1- Khiewa 
2- Pachir wa Agam 
3 - Behsud 
4- Chaparhar 
5- Ghani Khil 
B- Paktia Province 
1- Musa Khil 
2- Charnkani 
3 - Alisher 
4- Nader Shah Kot 
5- Mandozai 
6- Danda-patan 
C- Paktika Province 
1- \Nol-mamay 
2- Sultan Khil 
3- Yosuf Khil 
4- Sharana 
5- Sarawza 
6- \Naza Khowa 
7- Mata Khan 
D- Ghazni Province 
1- Andar 
E- Uruzgan Province 
1- Khas Uruzgan 
2- Gizab 
3- Trin Kot 
4- Chara 
F- Badghis Province 
1- Ghormach 
1 - Shar- e Safa 
2- Mizan 




4 - Kushk 
5- Gulran 
1- Farah Province 
1- Bala Buluk 
2- Shindand 




K- Helmand Province 
1- Bust 
2- Nawa 





M- Badakhshan Prov. 
1- Faizabad 
APPENDIX 12 
CORRESPONDENCE FROM M.O.A. TO 





ATTEN.vet and husb team. 
Sir, 
MINISTRY OF AGRICULTURE 
DEPUTY ANlMAL HUSBANDRY 
VET DEPT. 
Acoording to the understanding between ICRC and ministry of agriculture(MOA)on joint 
vaccine productin venture, the vaccine produced is to be bought by FAO for use only inside 
Afghanistan. After conducting the required quality test by F AO they are ready to purchase the 
vaccine. In this connection the FAO representative had already expressed their willingness to 
MOA and to ICRC Relief Co-ordinator. Similarly based on an understanding between vet 
dept and Mr.Rod Relief Co-ordinator the vaccine is to be released as early as possible.] 
herebv would like to state that anv untoward reaction of this vaccine will not be the 
resposibility oflCRC. Because this vaccine has been produced according to national 
standards and specifications as it used to be in the past. MOA permits the use of thi s vaccine 
in side the country. I would al so like to remind you of the content of our letter No.371 , which 
has already been sent to you and request you to expand yo ur activities and produce al I the vet 
vaccines that \Vere produced in thi s vaccine production before the internal conflicts. Because 
production of the mentioned vacc ines are absolutely necessary to reach humanitarian helps to 
the people. 
BEST REGARDS 
Qari mohd.Jameel saheeqi 
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